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ABSTRACT 
 
NCOA4 protein is involved in iron metabolism. Indeed, under low iron 
conditions, NCOA4 accumulates and promotes, as cargo receptor, the 
autophagic degradation of the iron-storage macromolecule ferritin. This process, 
called ferritinophagy, is critical to restore the appropriate cellular iron levels and 
could impair systemic iron homeostasis. Consistently, we have demonstrated 
that mice carrying genetic ablation of NCOA4 were unable to mobilize iron from 
deposits, featuring tissue iron overload as well as mild anemia. Because of 
impaired ferritinophagy, NCOA4 null mice displayed a severe mycrocitic 
hypocromic anemia and ineffective erythropoiesis when fed with an iron low 
diet. Conversely, they poorly tolerated an iron rich diet, dying prematurely for 
iron toxicity. Since in previous studies we discovered that nuclear NCOA4 is a 
chromatin binding protein that acts as a negative regulator of DNA replication 
origin activation, inhibiting the MCM2-7 DNA helicase, we also investigated 
whether NCOA4 could regulate DNA replication as a function of iron 
bioavailability. Treatment with iron chelators promoted a G1-arrest, blocking 
DNA replication origins activation. In cell fractionation experiments, we 
observed that iron depletion induced nuclear translocation of NCOA4, and by 
ChIP and co-immunoprecipitation assays we demonstrated that NCOA4 
increased its binding to DNA replication origins and to MCM2-7 complex, 
respectively. Silencing of NCOA4 induced an unscheduled activation of DNA 
replication under iron-depleted conditions that promotes replication stress and 
reduction of cell viability. In conclusion, our data indicate NCOA4 as a novel 
inter player coupling DNA replication origin activation to cellular iron levels. 
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1 BACKGROUNG 
1.1 Iron: the essential ion for life 
 
   Iron is a vital element for almost all organisms because of its ability to assume 
multiple oxidation states. Indeed, it can transiently cycle between divalent 
ferrous (Fe2+) and trivalent ferric (Fe3+) iron functioning as a cofactor for several 
hemoproteins (hemoglobins, catalases, peroxidases and cytocromes) and non-
heme iron containing proteins (ribonucleotide reductase) (Pantopoulus et al, 
2012). This property may also render the metal toxic to biological systems (as 
ferrous iron Fe2+): in presence of H2O2, normally produced during cellular 
respiration, it generates highly reactive hydroxyl radicals-Fenton reaction- that 
readily attack and damage organic macromolecules. However, in nature iron 
often adopts the oxidized state (Fe3+) which is insoluble at physiological pH. 
Because of this low solubility and high toxicity cells and organism have evolved 
a tight control over the uptake and the distribution of iron in order to avoid its 
excess but also its deficiency.  
 
1.2 Systemic iron homeostasis (absorption, utilization, recycling) 
 
   In mammals the absorption of inorganic iron involves firstly its reduction (Fe3+ 
 Fe2+) by ascorbate or by membrane associated ferrireductases (the best known 
is duodenal cytocrome b, DcytB) at the brush border of duodenal enterocytes. 
As there is little or no paracellular iron transport under normal circumstances, 
Fe2+ crosses the apical membrane of enterocytes through the divalent metal 
trasporter 1 DMT1/SLC11A2 (Gunshin et al, 1997).  
Iron contained in the prosthetic group of hemoglobin (Hb) is absorbed in a not 
well-defined way and the only carrier proposed is SLC46A1, mostly involved in 
folate absorption (McKie et al, 2008). However, after the disassembly of the 
macromolecule by heme oxigenase, free iron follows the same destiny taken by 
inorganic iron (Andrews et al, 2007).  
Depending on body’s requirements, then iron can be stored in ferritin 
macromolecule within cells and lost along the old enterocytes or it can be 
exported into the blood circulation by the only known basolateral carrier present 
in mammals called ferroportin (Slc40A1) (Mckie et al, 2000). There, it is first 
oxidized (Fe2+  Fe3+) by hephaestin, a multicopper oxidase associated to 
Slc40A1, and then delivered to all tissue by the glicoprotein transferrin (Tf).  
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Figure 1. Systemic Iron Homeostasis and Main Iron Flows 
Iron flows through a closed system with no active excretion mechanism. Iron can be 
absorbed only in Ferrous state (Fe2+- red bulet). Every day only 1-2 mg of iron can be 
absorbed, balancing iron losses and tissue needs. The majority of iron is recovered by 
splenic macrophages. 
 
Transferin has two high-afinity binding sites for Fe3+ and its holo form, holo-
transferrin, can bind two diferent membrane receptors: a highly afinity receptor 
TfR1, which is ubiquitously expressed and is involved in iron release to cels 
and a specific liver and bone marow receptor, TfR2, that binds to Tf with low 
afinity and appears to be regulatory (Nia et al, 2015). 
Under physiological conditions, transferin is partialy saturated (in humans 
30%, in mice 50%) and the percentage of saturation reflects body iron level: 
when it exceed 60%, non-transferin-bound iron accumulates in circulation and 
damages parenchymal cels since there is no active mechanism ensuring iron 
excretion (Hentze et al, 2010). Thus, iron levels can be controled only through 
a fine regulation of its enteric absorption and its splenic/hepatic recycling. 
Every day, 1-2 mg of iron are absorbed to offset iron loss due to desquamation 
of epithelial or enteric cels or bleeding but the majority of it (20-25 mg) is 
recovered from splenic and hepatic macrophages. These cels phagocitate 
senescent and damaged erythrocytes and catabolize hemoglobin to release iron 
in blood through feroportin carier (Fig. 1) 
The key mechanism that mammals have evolved to control systemic iron level 
afects mainly feroportin stability and is related to the hepatic hormone 
hepcidin. 
Hepcidin protein is a liver peptide of 25 amino acid encoded by HAMP gene. 
HAMP gene was soon linked to iron metabolism, being overexpressed in mice 
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livers subjected to iron overload (Pigeon et al, 2001). Indeed, hepcidin acts as a 
“ferroportin ligand” able to induce feroportin internalization and degradation 
(Nemeth et al., 2004) in order to limit iron availability, blocking iron uptake 
from enterocytes as wel as iron release from macrophages. 
Hepcidin production is basicaly regulated by the Bone Morphogenetic Protein 
6 (BMP6), a member of transforming growth factor-beta superfamily (Figure 2). 
This factor, in complex with Hemojuvenile coreceptor (Hjv), joins the liver BMP 
receptors type I (Alk2 or Alk3) and the type I (ACTRIA) to activate HAMP 
transcription via SMAD transcriptional complexes (Wang et al. 2005). 
Hepatocytes can “sense” iron overload and release BMP6, that in an autocrine 
manner potentiate the SMAD axis, as mentioned before. However, additional 
levels of control are exerted on hepcidin expression (Enns et al, 2013). When 
circulating iron levels increase, transferrin bufers this excess and the resulting 
Tf-Fe complexes bind not only to Tf-receptor 1, but also to the lower affinity 
receptor TfR2. On the hepatocytes membranes, TfR1 changes its conformation 
and alows the detachment of HFE protein, an atypical major histocompatibility 
complex class I molecule, that in turn stabilizes TfR2—Tf complex and 
promotes ERK-MAP kinase-depentent hepcidin expression. In this way, both 
serum iron and tissue iron act as a positive stimulus on HAMP gene in order to 
reduce iron absorption and recycling. 
 
  
Figure 2. Main signaling affecting HAMP transcription 
High tissue iron or serum iron and inflammation represent the major positive stimuli 
known to increase hepatic hepcidin transcription whereas erythropoiesis process, which 
require a constant supply of iron, act as negative stimulus. 
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The increase in hepcidin levels is also achieved in response to infections via 
cytokines such as IL-6 and the subsequent activation of JAK-STAT3 pathway. 
The latter has evolved as a defense mechanism to restrict serum iron availability 
to pathogens (Rishi et al, 2015).  
Otherwise, erythropoietic signals sent from bone marrow such as the BMP 
antagonist TWSG1 (Tanno et al, 2009) or the novel erythroid regulator, 
erithroferrone (ERFE) (Kauts et al, 2014) can override the regulation by iron 
stores and strongly suppress HAMP gene in order to keep up with the 
erythropoietic iron demand. In condition of anemia, tissue hypoxia blocks 
hepcidin expression firstly stimulating proliferation and differentiation of 
erythroid precursor through erythropoietin (EPO) and secondly, the stabilization 
of HIF transcription factors induces the expression of a specific liver protease 
(matriptase-2 or TMPRSS6) able to cleave Hvj and to interfere with 
BMP6/SMAD signaling (Silvestri et al, 2008 and Lakhal et al, 2011).  
 
1.3 Systemic Iron overload and iron deficiency  
 
   Either iron deficiency or iron excess could have deleterious effects on health 
leading to anemia or iron overload and hemocromatosis.  
Inadequate absorption of iron from diet can cause microcytic anemia especially 
during growth or pregnancy. Likewise, also abnormal high levels of hepcidin 
lower iron and cause anemia (Gozzelino et al, 2016). For example, patients with 
chronic inflammation (malignancies, infections, etc.) have higher amounts of 
inflammatory cytokines, which stimulates hepcidin and lead to ACD, Anemia of 
Chronic Disease. Furthermore, mutations in TMPRSS6 (matriptase-2) impair 
one of the negative control on BMP6/SMAD/hepcidin axis, leading to a 
hereditary form of iron deficiency called IRIDA (Iron refractory iron deficiency 
anemia).   
All the genetic alterations affecting proteins involved in hepcidin-ferroportin 
signaling lead to a form of primary iron overload belonging to Hereditary 
Hemocromatosis (HH), the most frequent recessive inherited disorder of the 
western world. A common mutation found in HH affects HFE gene (C282Y 
substitution) and abolish HFE localization on cell surface (Feder et al, 1997). 
Other mutations have been found in TFR2 or in HVJ gene leading to a more 
severe or a juvenile form of the disease, respectively, whereas in rare case 
hepcidin-encoding gene itself can be mutated.  
Studies in mice carrying HFE, TFR2 or HJV genetic inactivation have clarified 
the role of the main signaling pathways involved in iron homeostasis and have 
demonstrated how alterations in these axes lead to inappropriately low 
expression of hepcidin which fails to be modulated in spite of liver iron overload 
and related increased BMP6 expression.  
Moreover, a peculiar form of HH presents gain-of-function mutations on 
ferroportin gene (FPN1). In this condition, hepcidin levels reflects iron deposits 
but the carrier ferroportin results insensitive to hepcidin down-downregulation. 
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Iron overload could also be associated to certain congenital disorders, such as 
Beta-thalassemia, characterized by ineffective erythropoiesis, accumulation of 
erythroid precursors, hypoxia and the release of antagonist factors of BMP6 
signaling (i.e. ERFE), that completely block hepcidin function despite high iron 
levels.  
Whatever the cause of HH, when iron exceeds body needs, it saturates all 
transferrin molecules and circulates in a toxic form as non-transferrin bound iron 
(NTBI) loosely chelated by albumin or by small organic molecules such as 
citrate (Brissot et al, 2012). Membrane transporter such as DMT1 or ZIP 14 have 
been proposed as possible candidate for NTBI uptake (Liuzzi et al, 2006 and 
Gunshin et al, 2005). Thus, iron can accumulate in several organs: firstly in liver, 
a primary site of storage, but also in heart, impairing cardiomiocytes contractility 
or in pancreas and in all ductless gland. Interestingly, in HH the key organ in 
iron recycling, the spleen represents the only site “free of iron” because of FPN 
stabilization in splenic macrophages secondary to low hepcidin production. 
In all cells, the excess of ferrous iron (Fe2+) can donate electrons beginning 
cycles of redox reactions that readily attack and break lipids, nucleotides and 
proteins leading to cell death.  
Although the inappropriate amounts of free iron in HH, method to determine 
plasma free iron are not well defined. On the contrary, the evaluation of serum 
iron, transferrin saturation and the determination of liver iron concentration 
(LIC) from liver biopsy, represent the main standard to monitor iron overload. 
Moreover, when tissue iron levels increased, a glycosylated isoform of L-ferritin 
circulates in bloodstream. This form contains very low amounts of iron, probably 
derived from damaged tissue or splenic macrophages that can easily be detected 
as an indirect marker of iron burden (Taher et al, 2009).  
 
1.4 Cellular iron homeostasis: from uptake to storage 
 
   Besides the complex systemic iron metabolism, also cells coordinately 
regulate iron uptake, storage, utilization and final export. The circulating 
complex Fe3+-Tf bound to the TfR, is internalized into cells by clathrin-
dependent endocytosis (Hentze et al. 2010). There, low pH of vescicles allows 
the release of Fe3+ from the complex Tf-TfR and its reduction by STEAP 
metalloreductases, prior its export to cytosol via DMT1 transporter. Then Apo-
Tf can be recycled and secreted into the bloodstream because of the low affinity 
to transferrin receptor. All cells that rapidly divide, such as erythroid progenitor, 
intestinal epithelial cells or also neoplastic cells, show increased needs for iron 
and express high TfR1 levels and are particularly addicted to Tf/TfT1 cycle 
(Gkouvatsos et al, 2012). 
Newly acquired iron immediately associates with several low molecular-weight 
chelates, such as citrate, ATP, AMP, pyrophosphate or peptides in a transient 
pool called Labile Iron Pool (LIP). From LIP, iron can enter the mitochondria, 
the major site of its utilization via mitoferrin transporter (Mfrn or SLC25A37) 
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to synthetize heme or iron sulfur clusters whereas all the excess can be stored in 
a redox inactive form (Fe3+) into ferritin.  
Mammalian ferritin is a heteropolymer made of 24 subunits of FTL (light) and 
FTH (heavy) chains that associate in a spherical cage able to accumulate up to 
4500 iron atoms. H-ferritin has a ferroxidase activity necessary for iron 
deposition as ferric oxy-idroxide phosphate while L-ferritin promotes iron 
nucleation. It has been demonstrated that (in cells and in vitro) iron loads into 
ferritin through a metallochaperone molecule called (poly-(rC)-binding protein), 
an RNA binding protein with cytosolic and nuclear localization. In mammals, 
the proportion of H and L subunits can vary and depend on tissue function. 
Indeed ferritin found in heart and brain is rich in H chains to sequester and 
inactivate ferrous iron whereas in spleen and in liver predominates L-ferritin, a 
form of the macromolecule more stable which may contains a larger amount of 
iron (Arosio et al, 2009). Interestingly, ferritin predominantly of heavy chains 
has been also observed in nucleus and probably protects DNA from iron-induced 
damage (Surguladze et al, 2005).  
The excess of intracellular iron can also be eliminated through Ferroportin 
carrier.  
Iron levels in cells rely on proteins involved in its metabolism such as ferritin 
(storage), transferrin receptor (uptake) or ferroportin (export) and are regulated 
by iron-regulatory protein 1 and 2 (IRP 1/2). IRP1 and IRP2 are homologous to 
mitochondrial aconitase and have a cubane of Iron-Sulfur cluster (ISC) in their 
active site. They are also able to bind to specific stem-loop structures of 25-30 
nucleotides called IRE -Iron Responsive Element- which are present in the 5’ 
and 3’ untranslated region (UTR) of lots of mRNAs (Wilkinson et al, 2014). 
Interaction of IRP proteins to hairpin structures in 5’UTR of mRNA (such as in 
ferritin, ALAS-2, ferroportin, HIF2α) mainly decrease translation whereas in 3’ 
UTR of mRNA (contained in TfR1, DMT1) stabilize translation.   
In iron-replete cells, iron can ligate IRP1 as a F-S cluster keeping the protein in 
a close conformation unable to bind to IRE and can induce IRP2 proteosomal 
degradation through the stabilization of the Fbox and leucin rich repeat protein 
5, FBxL5. In this circumstance, iron level lowers because ferroportin and ferritin 
mRNA are free to be translated providing iron storage and export whereas TfR1 
mRNA is cleaved, blocking iron uptake. Differently, in iron deficient cells 
Fbxl5-dependent degradation of IRP2 decreases and IRP1 adopts its IRE-
binding conformation after the loss of the Fe-S cluster (Nakayama et al, 2011). 
Iron levels can rapidly increase not only through the effect of IRP1/2-IRE 
binding but also through the mobilization of iron from deposits. Indeed, ferritin 
can be sequestered in double-membrane structures called autophagosomes and 
delivered to lysosomes for degradation and iron release. This new process is 
called ferritinophagy and involves NCOA4 (Nuclear receptor coactivator 4) 
protein as a cargo receptor for ferritin (Mancias et al, 2014; Dowle et al, 2014). 
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1.5 Iron levels and cel cycle: evidence of a an iron-dependent check-point 
 
  The orderly progression among the main phases of the cel cycle (G1-S-G2-
M) is governed by CDK protein activities. These kinases recognize and 
phosphorylate their substrates when bound to cyclins, which expression peaks in 
a coordinated manner with transition from one phase to another (Figure 3) 
During the low CDK activities period, from late mitosis through G1 phase, cel 
organizes the assembly of the pre-replication complexes (pre-RC) onto DNA. 
This first process, known as licensing, involves the cooperation among origin 
recognition complex (ORC), cel division cycle 6 (CDC6) and CDC10-
dependent transcript 1 (CDT1) proteins to engage the DNA helicase complex 
MCM2-7 onto potential DNA replication origin. This loaded helicase is inactive 
at this stage. 
 
 Figure 3. Schematic representation of cel cycle 
Specific CDK-cyclin complexes are responsible for driving the various events known 
to take place during interphase in a sequential and orderly fashion. 
 
When external signals stimulate cels to proliferate, cyclin D levels increase, 
enabling CDK4/6 to initiate Rb phosphorylation and inactivation. Thus, E2F 
transcriptional factors are freed to promote cyclin E transcription, alowing the 
complex CDK2-Cyclin E to activate a positive loop on RB-suppression/E2F 
activation and overcome the restriction point at the boundary of G1/S phase. 
Moreover, E2F factors promote transcription of genes responsible for DNA 
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synthesis (DNA pol α and δ, PCNA) and cyclin A to progress throughout the S-
phase. 
Activated CDKs (cyclin E/A with CDK2), together with Cdc7/DDK (Dbf4 and 
Drf1 dependent kinase) phosphorylate different members of the pre-replication 
complexl, triggering the origin firing process in which the licensing factors 
CDC6 and CDT1 are released from chromatin (Delmolino et al, 2001; Li et al, 
2003) and other replication factors, such as CDC45 and the GINS 
heterotetramer, (Psf1-3;Sld5) bind to licensed origins to form the  Pre-IC (Pre-
initiation complex) or CMG (Cdc45-MCM2-7-GINS) complex. The CMG 
represents the processive helicase able to unwind double strand DNA and open 
the replication bubble. There, RPA protein binds to single strand DNA, recruits 
DNA polimerases and allows, together with processive factor PCNA, the 
synthesis of DNA.  
Finally, if all DNA is replicated correctly, cells can progress through G2 phase 
and prepare mitosis. The G2/M transition is marked by Cdc25 phosphatase 
activation and the removal of inhibitory phosphate on CDK1-cyclin B 
complexes.  
Cells have evolved different regulatory pathways able to monitor the successful 
completion of each phase prior to proceeding to the next one (Hartwell et 
Weinert, 1989) and to arrest the cell cycle temporarily not only in case of 
damaged DNA but also in case of low nutrient availability. Besides basic organic 
macroelements such as glucose or lipids, also microelements are necessary.  Iron 
is an essential microelement for fundamental biological processes in 
mitochondria, cytosol and nucleus. For example, numerous proteins involved in 
electron transfer but also in DNA replication and repair, like the three DNA 
polymerases (Pol alfa, Pol delta, Pol epsilon) or DNA helicases (XPD, FANCJ, 
RAD3) and DNA primase (regulator subunit PRIM2) contain a conserved Fe-S 
domain necessary for their activity. Moreover, Ribonulceotide Reductases 
(RNRs) have a small subunit (R2) that continuously needs iron to form a diferric 
tyrosil radical necessary to reduce ribonucleotides in deoxyribonucleotides 
(dNTPs), the building blocks of DNA (Zhang C. et al, 2014).  
Thus, cells have to coordinate their proliferation also to intracellular iron levels.  
When quiescent cells are stimulated to re-enter the cell cycle, they increase iron 
uptake through enhanced TfR expression (Kwok et Richardson, 2002) and 
accordingly, depletion of the intracellular iron pool of cycling cells lead to cell 
cycle arrest (Le et Richardson, 2002).  
Studies focused on the effects of iron chelators (deferoxamine, DFO) have 
demonstrated that low iron blocks cells in late G1 phase suggesting the existence 
of a specific iron-sensitive cell cycle checkpoint. Indeed, analogous to the DNA 
damage checkpoint in which damaged DNA blocks replication in order to 
maintain genome stability, it would also be dangerous if cells began DNA 
synthesis without sufficient resources to complete the process.  
The addiction of proliferating cells to iron is also underlined by the higher 
susceptibility of cancer cells, such as neuroblastoma cells, to iron deprivation, to 
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the point that iron chelators represent an alternative therapeutic strategy to treat 
some cancers.  
The exact molecular mechanism underlining cell cycle arrest after iron depletion 
has not been fully understood. At first, it was thought that Fe chelation only 
inhibited RNR activity. In fact, recent studies have shown that other proteins 
involved in cell cycle progression are affected.  
In iron deficiency, the expression levels of cyclin E, the specific catalytic subunit 
of CDK2, are reduced blocking cells in late G1 phase. Moreover, some CDKs 
inhibitors, such as p21 or p27 have been found to be up regulated in a p53-
dependent manner after deferoxamine treatments. Indeed, iron chelation induces 
p53 phosphorylation at serine 15 and 37 preventing any association with mdm-
2 and the subsequent proteosomal degradation. Stabilized p53, in turn functions 
as a positive transcriptional factor for CDKs inhibitors in order to arrest cell 
cycle. Interestingly, p53 also promotes the transcription of a specific subunit of 
RNR, p53R2 supplying the production of nucleotides in case of DNA damage 
(Tanaka H et al, 2000). 
Low iron levels also mimics hypoxic state by interfering with Prolyl 
Hydroxylases functions, leading to increased stabilization of HIF1α. 
Translocated to the nucleus, HIF1α targets many genes by binding to the 
hypoxia-responsive element contained in their promoter, such as TfR1, which 
then functions to increase intracellular iron (Bianchi L et al. 1999).  Moreover, 
HIF1α also interacts and stabilizes p53 (An WG et al. 1999) and can promote 
apoptosis, upregulating pro-apoptotic factors such as BNIP3 (Bruick RK, 2000). 
Interestingly, it has been demonstrated that HIF1α binds to Cdc6, a member of 
the pre-replication complex, inhibiting the phopshorylation induced by DDK and 
the formation of the active helicase represented by the CMG complex, in order 
to avoid DNA duplication (Hubbi et al, 2003)   
 
1.6 NCOA4 protein: a multifunctional protein involved in iron metabolism 
and DNA replication 
 
   NCOA4 gene (also known as RFG, ELE1 or ARA70) encodes a 70-kDa 
protein that is ubiquitous expressed. Data obtained from our laboratory showed 
that NCOA4 is highly expressed in liver, duodenum, spleen and testis in adult 
mice (data not shown). The first role associated to NCOA4 protein was as a 
transcriptional coactivator for several nuclear receptors, including  androgen 
receptor (AR), estrogen receptor (ER), peroxisome proliferator-activated 
receptor gamma (PPARɣ) (Yeh and Chang, 1996) and also thyroid hormone 
receptor (Moore JM et al, 2004). Indeed, it possesses two specific nuclear 
receptor binding motifs: LXXLL, mediating the interaction with TR and PPARɣ 
and FXXLF involved in AR and ER interactions. Moreover, the amino acid 
sequence of full length proteins reveals that there are no specific structural or 
functional domains except for the coiled-coil domain (cc) present in its N-
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terminal portion, enabling the dimerization and oligomerization of the protein 
(Monaco et al, 2001).  
This property is especially relevant for NCOA4-RET (or RET/PTC3), a chimeric 
protein resulting from a common paracentric inversion of the 10 chromosome 
firstly found in Papillary thyroid cancers (in 10-20 % of all PTCs) (Santoro et al, 
1994). This recombination leads to the fusion of the first exons of NCOA4 gene 
with the last nine exons of RET gene, encoding the tyrosine kinase portion of 
RET receptor. It has been demonstrated that NCOA4-RET is directly involved 
in thyroid tumorigenesis and possesses oncogenic properties. Indeed, the 
dimerization mediated by the NCOA4 N-terminal portion leads to the ligand-
independent  activation of the catalytic portion of RET, and of  the downstream 
signaling pathways such as MAP Kinase and PI3K-AKT cascades, promoting 
uncontrolled proliferation and survival.  
The association of NCOA4-RET rearrangement to more aggressive PTC 
subtypes (Basolo et al, 2002) has suggested that not only the activity of RET 
oncogene but also the loss of NCOA4 protein could contribute to cellular 
transformation. Interestingly, NCOA4 expression is reduced in different prostate 
cancer cell lines (Tekur et al, 2001) and in a subset of HER2-positive breast 
cancer, identifying NCOA4  as a potential tumor suppressor.  
To date, studies of sequencing of numerous tumor samples detected NCOA4-
RET in non small cell lung cancer (adenocarcinomas) (Wang et al, 2012) and in 
colon carcinoma (Le Rolle et al, 2015). 
Recently, our group has demonstrated that NCOA4, via its N-terminal portion, 
interacts with the mini chromosome maintenance protein MCM7, a component 
of the DNA helicase MCM2-7 (Bellelli et al, 2014). Via such interaction, 
NCOA4 blocks the CMG helicase activity and the opening of the replication 
bubble necessary to achieve DNA replication origin during S-phase. Through 
experiments in Xenopus laevis egg extracts, a cell-free system that recapitulate 
DNA replication after the addiction of demembranated sperm nuclei, we 
observed that the recombinant full-length protein completely abolish DNA 
synthesis. Moreover mouse embryonic fibroblasts (MEFs) derived from a 
transgenic mouse Knock Out for NCOA4 display uncontrolled DNA origin 
activation and replication stress that lead to premature senescence. Thus, 
NCOA4 protein exerts a negative control over DNA duplication. Further studies 
are needed to understand how this mechanism is affected during cell cycle and 
which could be the cellular contests requiring this additional form of regulation.  
Two different studies have also described NCOA4 involved in cellular iron 
metabolism, an apparently unrelated function for this unique protein. At 
molecular level NCOA4 can bind to H isoform of ferritin, through a specific 
tryptophan residue (W497) present in its C-terminal conserved  portion  and with 
certain proteins of the catabolic autophagic machinery (ATG8-like proteins such 
as GABARAP). Indeed, NCOA4 acts as a cargo receptor delivering ferritin to 
autophagosomes, little vesicles that fuse with lysosomes in order to mobilize 
iron from storages. This process, called ferritinophagy is affected by cellular iron 
levels and is mainly regulated by NCOA4 turnover (Mancias et al, 2016). Indeed, 
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in iron replete conditions, NCOA4 binds to iron, in a not fully understood way, 
folding into a conformation recognized by the E3 ubiquitin ligase, HERC2. Then 
NCOA4 levels lower whereas ferritin macromolecules accumulate to capture 
iron. On the contrary, in iron deficiency, NCOA4 interacts with the target ferritin 
and promotes its autophagic degradation restoring appropriate intracellular iron 
concentration. 
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 2 AIMS OF THE STUDY  
 
   NCOA4 protein has been recently involved in different functions. It was firstly 
described as a coactivator of several nuclear receptors, including peroxisome 
proliferator activated receptors α and γ, receptors for steroid hormones and 
thyroid hormones, promoting their transcriptional activity.  
NCOA4 also acts as a negative regulator of DNA synthesis binding to DNA 
replication origins and directly interfering with the MCM2-7 helicase function. 
Its ablation in mouse embryonic fibroblasts allows unscheduled DNA origin 
activation resulting in replicative fork stalling and genome instability that lead 
to cellular senescence. 
On the other hand, cytosolic NCOA4 protein plays a crucial role in cellular iron 
metabolism acting as a cargo receptor for ferritin, the iron storage 
macromolecule. In iron-depleted conditions, NCOA4 accumulates, avoiding 
HERC2 ubiquitination and proteosomal degradation, and delivers ferritin to the 
autophagic catabolic route in order to restore iron levels. This new process, 
called ferritinophagy helps to establish the appropriate cellular iron levels, in 
addition to the IRP1 and IRP2-dependent control.  However, the impact of this 
process in systemic uiron homeostasis maintenance has not been investigated. In 
addition how iron levels may insist on activation of DNA replication origins via 
NCOA4 is still known. 
First aims of this thesis was to study the role of NCOA4-mediated ferritinophagy 
in living animals carrying  total ablation of NCOA4 gene and to evaluate how 
this process may affect systemic iron homeostasis in normal condition and also 
in iron deficiency and overload conditions.  
To these aims we: 
-Evaluated ferritin levels in key organs for iron metabolism (spleen, bone 
marrow, liver and duodenum), hematological parameters and key biochemical 
markers of iron status (serum iron, transferrin saturation) in NCOA4 deficient 
mouse model at basal level .  
-Evaluated the hematological phenotype of NCOA4 deficient mouse and in 
particular erythoipoiesis process  after exposure to 5 and 7 months of low-iron 
diet in order to study iron  mobilization from tissue stores in stress conditions   
-Evaluated the phenotype of NCOA4 deficient mice fed with an iron-rich diet. 
Second aims of this thesis was to clarify whether iron bioavalaibility affects 
DNA replication also through NCOA4 functions.   
To this aim we: 
-Evaluated NCOA4 nuclear localization and its binding to replisome in iron 
deficient condition 
-Evaluate NCOA4 recruitment to DNA replication origins in HeLa cells by 
chromatin immunoprecipitation in iron deficient conditions 
-Evaluate cell cycle progression in normal and NCOA4 deficient cells exposed 
to iron deficiency and whether changes in “IDR”, Iron Depletion Response, in 
NCOA4 null cells might affect cell viability.  
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3 MATERIALS AND METHODS  
 
3.1 Cell Culture 
   HeLa cells were cultured in RPMI supplemented with 10% fetal bovine serum 
(FBS), 50 mg/ml penicillin-streptomycin, and 2 mM L-glutamine. WT and 
NCOA4-null MEFs were produced and cultured as described by Bellelli et al. 
(2014). To induce iron-overload conditions, MEFs were treated for 16 hours 
with 10 mg/ml of ferrum ammonium citrate (FAC), whereas, for growth under 
iron-deficient conditions, cells incubated for 24 hr in FAC were released in 
normal medium containing 50 mM deferoxamine (DFO).  
Cell synchronization by nocodazole arrest. HeLa cells were incubated with 100 
ng/ml nocodazole for 16 hours. Upon mitotic shake off, M-phase arrested cells 
were collected, washed 3 times with 1X phosphate-buffered saline (PBS) and 
plated in complete medium. Subsequently, cells were harvested at different time 
points or treated with DFO and subjected to fractionated protein extraction. 
 
3.2 Cell fractionation  
 
   For subcellular fractionation cytosol /nucleosol, cells in the mid-exponential 
phase of growth were collected by scraping from the culture dish after two 
washings with 20 ml ice-cold 1X phosphate-buffered saline (PBS). Subcellular 
fractions were prepared using the NE-PER nuclear and cytoplasmic extraction 
kit (Pierce Biotechnology, Rockford, IL).  
To isolate chromatin-bound proteins from cytosolic and nucleosolic proteins, 
cells were incubated on ice for 10 min with ice-cold CSK buffer (10 mM PIPES, 
pH 6.8, 100mM NaCl, 300 mM sucrose, 1mM MgCl2, 1 mM EGTA, 1mM DTT, 
1 mM phenylmethylsufonyl fluoride, 10 g/ml aprotinin) containing 0.5% 
Triton X-100 (Pierce Biotechnology, Rockford, IL). Chromatin-bound and un-
bound proteins were then separated by low speed centrifugation (3,000 rpm, 3 
min at 4°C).To solubilize chromatin-bound proteins samples were incubated 
with Laemmli buffer (60 mM Tris-Cl pH 6.8, 2% SDS, 10% glycerol, 5% β-
mercaptoethanol, 0.01% bromophenol blue) for 10 minutes at 99C°. For each 
fraction, protein amounts deriving from comparable number of cells were 
analysed by SDS-PAGE and Western blotting. 
To obtain total protein extracts, cells and tissues were lysed in a buffer 
containing 50 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (pH 
7.5), 1% (vol/vol) Triton X-100, 150 mM NaCl, 5 mM EGTA, 50 mM NaF, 20 
mM sodium pyrophosphate, 1 mM sodium vanadate, 2 mM 
phenylmethylsulphonyl fluoride and 1 ug/ml aprotinin. Lysates were clarified by 
centrifugation at 13200 rpm  for 30 min. Lysates containing comparable amounts 
of proteins, estimated by Bradford assay (Bio-Rad, Munchen, Germany), were 
immunoprecipitated with the required antibody or subjected to direct Western 
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blotting. Immune complexes were detected with the enhanced 
chemiluminescence kit (Amersham Pharmacia Biotech, Little Chalfort, UK). 
Immunoblotting was carried out with specific antibodies.  
For binding assay (pull-down), HeLa cell lysates were incubated with 
recombinant proteins immobilized to resin (glutathione sepharose 4B for GST-
tagged protein and Ni-NTA Agarose matrix to purify NUS/His tagged protein). 
Bound proteins were detected by immunoblot analysis.  
 
3.3 Chromatin Immunoprecipitation (ChIP) 
 
   Chromatin immunoprecipitation was performed from exponentially growing 
HeLa cells using purified anti-NCOA4. Cells were first cross-linked for 10 min 
by adding formaldehyde to a final concentration of 1%. Cross-linked cells were 
then blocked using glycine to a final concentration of 1.25 M, then lysed in  SDS 
lysis buffer containing protease inhibitors  and sonicated to reduce DNA to a  
length between 150 and 500 bp. The sheared chromatin extract was then frozen 
in aliquots at –80oC until required. The supernatants diluted 10-fold in ChIP 
dilution buffer with protease inhibitors and precleared with 60 μl salmon sperm 
DNA/protein A Agarose-50% slurry for 60 min at 4°C. Cross-linked chromatin 
was incubated overnight with 10 ug of antiNCOA4 antibody or control IgG in a 
total volume of 1 ml at 4°C. Antibody-protein-DNA complexes were isolated by 
immunoprecipitation with 60 μl salmon sperm DNA/protein A. After extensive 
washing, pellets were eluted by freshly prepared elution buffer (1% SDS, 0.1 M 
NaHCO3). Formaldehyde cross-linking was reversed by 5-12-h incubation at 
65°C after adding 20 μl 5 M NaCl. Samples were purified throughphenol-
chloroform extraction and used as a template in PCR. Primers for PCR were as 
follows: 
Lamin B2 origin (ORI): 
Forward        GGCTGGCATGGACTTTCATTTCAG 
Reverse         GTGGAGGGATCTTTCTTAGACATC 
Control region (CTR) 
Forward        CTGCCGCAGTCATAGAACCT 
Reverse         ATGGTCCCCAGGATACACAA 
c-Myc origin: 
Forward        TATCTACACTAACATCCCACGCTCTG 
Reverse         CATCCTTGTCCTGTGAGTATAAATCA 
Control region: 
Forward       TTCTCAACCTCAGCACTGGTGACA 
Reverse        GACTTTGCTGTTTGCTGTCAGGCT 
 
Real-time PCR experiments were carried out in triplicate, using SYBR green 
mastermix (Bio-Rad, Munchen, Germany). NCOA4 Enrichments at origin 
region (ori) with respect to non origin containing region (non ori) region at each 
loci were calculated with delta Ct method.  
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3.4 Histology Analysis 
 
   Formalin-fixed, paraffin-embedded (FFPE) sections (5 mm thick) were stained 
with H&E by conventional methods or deparaffinized and rehydrated by 
passages through xylene and alcohol series for Perl’s Prussian blue or 
immunohistochemical (IHC) staining. For Perl’s blue staining, liver, duodenal 
and spleen section were incubated for 30 minutes with a solution 1:1 ferrocyanide 
and hydrochloric acid and then washed in water, counterstained with filtered fat 
red stain and mounted. For the  IHC staining,  endogenous peroxidase activity 
was blocked by treatment with 3% hydrogen peroxide (30 min at room 
temperature). Antigens were retrieved by incubating tissue sections for 15 min 
in boiling citrate buffer (1 mM, pH 6.0). Slides were blocked in 1% BSA for 1h 
at room temperture followed by o.n. incubation with primary antibodies  anti 
FPN and for 30 min at room temperature with biotinylated goat anti-rabbit 
antibody (Vector Laboratories, Burlingame, CA, USA); the stain was visualized 
with 3,3'-Diaminobenzidine (DAB) (SIGMA-Aldrich). 
 
3.5 RNA Extraction and RT-PCR 
 
   RNA was isolated from frozen mechanically fractured  mouse liver by using 
TRIzol reagent (Invitrogen) and purified with chloroform and precipitated with 
isopropanol/ethanol passages. RNA (1 mg) was reverse-transcribed with a 
Quantitec reverse transcription kit (QIAGEN). 
qRT-PCR reactions were done in triplicate, and fold changes were calculated 
with the following formula: 2 (sample 1 DCt  sample 2 DCt), where DCt is the 
differ difference between the amplification fluorescence threshold of the mRNA 
of interest and the mRNA of the gapdh used as an internal reference. The primer 
sequences used for qPCR are:  
FPN Forward CTACCATTAGAAGGATTGACCAGCTA  
FPN Reverse ACTGGAGAACCAAATGTCATAATCTG  
FTH1 Forward TGGAACTGCACAAACTGGCTACT  
FTH1 Reverse  ATGGATTTCACCTGTTCACTCAGATA  
GAPDH Forward CATGGCCTTCCGTGTTCCTA  
GAPDH Reverse ATGCCTGCTTCACCACCTTCT  
HAMP Forward TGTCTCCTGCTTCTCCTCCT  
HAMP Reverse  CTCTGTAGTCTGTCTCATCTGTTG  
TfR Forward GGTGATCCATACACACCTGGCTT  
TfR Reverse TGATGACTGAGATGGCGGAA  
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3.6 Retrovirus-mediated MEFs transduction 
 
   pBABE Puro NCOA4 full lenght C and N terminal portion or the empty vector 
were transfected into Phoenix-eco cells and, after 48 hours, viral supernatants 
were harvestedand used to infect primary NCOA4 +/+ or -/- MEFs. Forty-eight 
hours after infection cells were used to analyze ferritin accumulation and 
degradation upon FAC treatment and release in DFO as previously descrived. 
 
3.7 Tissue and Serum Iron Determination 
 
   For iron concentration measurements, spleen and liver mouse tissues were 
dried overnight at 110°C, dissociated mechanically, weighed, and digested 
in 1 ml of 3M HCl and 0.6 M trichloroacetic acid for 20 hr at 65°C. The total 
non-heme iron content was then measured using the bathophenanthroline 
method. Serum iron and transferrin saturation (the ratio of serum iron and total 
iron binding capacity) were calculated using the serum iron/unsaturated iron 
binding capacity (UIBC) and the total iron binding capacity (TIBC) kits (Randox 
Laboratories) according to the manufacturer’s instructions. 
 
3.8 Flow Cytometric Analysis of Mouse Bone Marrow erytroblast 
precursors.  
 
   Flow cytometry was carried out with the FACSCantoTM flow cytometer 
(Becton Dickinson, San Jose, CA, USA). Bone marrow cells were stained with 
phycoerythrin rat anti-mouse Ter119 (BD Biosciences) and antigen-presenting 
cell rat anti-mouse CD44 (BD Biosciences) for 30 minutes in the dark at 4°C 
and then analyzed by flow cytometry within 1 hour.  
Apoptosis was evaluated by using fluorescein isothiocyanate (FITC) Annexin 
V Apoptosis Kit I (BD Pharmingen 556547). Briefly, cells were washed twice 
with cold phosphate-buffered saline and then resuspend in 1X Binding Buffer at 
a concentration of 1*106cells/mL. 1*105cells were incubated with 5mL of 
FITC Annexin V and propidium iodide (PI) for 15 minutes at room temperature 
in the dark and then analyzed by flow cytometry within 1 hour. 
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4 RESULTS 
4.1 Impaired ferritinophagy in NCOA4 deficient mice promotes tissue 
ferritin accumulation 
 
   In order to clarify the role of NCOA4-mediated ferritinophagy at systemic 
level, we evaluated ferritin in key tissues for iron metabolism in a mouse model 
carrying genetic inactivation of NCOA4 gene.  
We analyzed protein extracts from liver, spleen, duodenum and bone marrow of 
NCOA4-/- and wild type 8-week-old mice by western blotting. As shown in 
figure 4A, NCOA4-/- mice displayed ferritin accumulation in all tissue analyzed 
compared to wild type mice. Moreover, iron content obtained from liver (Liver 
Iron Content, LIC) and spleen (Spleen Iron Content, SIC) biopsy of knockout 
mice was significantly higher than control mice (Fig. 4B).  
 
 
Figure 4. Total Ablation of NCOA4 Gene Results in Tissue Ferritin Accumulation 
A. Western blot analysis of ferritin (FTH1) and tubulin protein levels derived from liver, spleen, 
duodenum and bone marrow of two-old months NCOA4 WT (+/+) and null (-/-) female and 
male mice. 
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B. Non-heme iron content were determined from spleen (SIC) and liver (LIC) of NCOA4 WT 
(+/+) and null (-/-) female and male mice. Mean values of 3 animals for genotype (control 
NCOA4+/+ and null mice NCOA4-/-) were graphed. Errors bars indicate standard error. 
Asterisks refer to a statistically significant difference: **P<0.01, ***P<0.001. 
 
We also confirmed tissue iron loading in NCOA4 -/- mice by Perls’ blue 
staining: in liver, spleen and duodenum sections of KO animals, strong blue 
staining reflected the increased ferritin accumulation (Fig. 5). 
 
 
Figure 5. NCOA4 deficient mice display increased iron accumulation. 
Representative Pearls’ Prussian Blue staining of liver, spleen and duodenum from section of 
NCOA4 -/- and +/+ mice. The blue staining reveal iron deposition.  
 
 
We next analyzed markers of systemic iron status such as transferrin saturation, 
serum iron and serum ferritin. As shown in the graph (Fig. 6) serum iron level 
and transferrin saturation were higher in null mice compared to WT (p value 
<0,05). Accordingly with tissue iron loading, serum ferritin increased as well in 
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null mice with respect to wild type animals. The highest levels of circulating iron 
in knockout animals reflected tissue iron loading but could also suggest an 
impaired iron utilization. 
 
 
Figure 6. Increased Hematological Markers of Iron Status in NCOA4-Deficient 
Mice. 
Serum iron concentration, serum ferritin concentration and percentage of transferrin saturation 
were evaluated from 2 months old mice. Mean values of 4 mice for genotype (control NCOA4 
WT; null mice NCOA4 KO) were graphed. Errors bars indicate standard error. Asterisks refer 
to a statistically significant difference: *P<0.05.  
 
4.2 The Hepcidin-ferroportin axis limits iron absorption in NCOA4 
null mice 
 
   Since the impaired ferritinophagy in NCOA4 null mice increased tissue and 
serum iron levels, we focus our attention on the physiological response activated 
in vivo to counteract the iron overload, eg the Hepcidin-dependent 
downregulation of ferroportin (FPN). By Real Time PCR we found that the 
hepcidin gene transcription (HAMP) was significantly upregulated in the liver 
of NCOA4 null mice compared to control (fig. 7A). 
 As mentioned before, HAMP transcription is under control of multiple 
signaling. We evaluated phosphorylation status of SMAD proteins, which are 
activated by BMP6/HVJ signaling and MAP-kinase proteins activated by TfR2 
receptor in order to dissect the positive stimuli affecting HAMP expression. As 
shown by western blotting analysis (Fig.7 B), mice only ERK1/2 proteins 
(MAPK) resulted hyperphosphorylated and activated in comparison to WT, 
suggesting a stimulation by saturated transferrin on TfR2 while the hepatic 
autocryne BMP6 signal seemed not to be involved. Similarly, IRP2 protein 
levels, which are affected by labile iron pool, were not increased in NCOA4 null 
mice liver (Fig 7C). Consistently, Tfr1 and FTH1 mRNA, whose stability is 
under IRPs control were not changed (Fig 7D). 
As hepcidin expression increased, we investigated ferroportin level in duodeni 
of null mice. Immunohystochemical analysis of the duodenum clearly revealed 
the reduction of ferroportin levels in NCOA4 null mice (Fig. 7D) because of its 
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hepcidin-dependent degradation. These first data revealed that the impaired 
ferritinophagy in NCOA4 null mice increased iron deposits in key iron tissue 
such as liver and spleen. However, the hepcidin-mediated ferroportin 
downregulation and the consequent reduction of iron absorption, counteracted, 
at least in part, dangerous iron overload. 
 
 
Figure 7. Up-regulation of HAMP gene mediated ferroportin downregulation in 
NCOA4 deficient mice.  
A. Real time analysis RT-PCR of HAMP mRNA in livers from WT and NCOA4 null female 
and male mice. mRNA ratio was normalized to a WT control mice mean value of 1. Mean values 
of 4 mice for genotype (control NCOA4 WT; null mice NCOA4 KO) were graphed. Errors bars 
indicate standard error. Asterisks refer to a statistically significant difference: **P<0.01 
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B. Western blot analysis of p-MAPK and p-SMAD protein levels from liver extracts of 2 old 
female and male WT (+/+) and KO (-/-) mice. Total MAPK and total SMAD protein were used 
as loading control.  
C. Western blot analysis of IRP2 and TfR1 protein levels from livers extracts as in B. 
D. Real time analysis RT-PCR of TfR1 and FTH1 mRNA from livers as in A.  
E. Representative immunoistiochemical analysis of ferroportin (FPN) in duodenum sections 
from NCOA4 WT and null mice. The arrow indicates the basolateral presence of the carrier 
ferroportin.  
4.3 NCOA4 null mice were unable to mobilize iron reserve under iron 
deprivation 
 
   Since the majority of body iron is used for hemoglobin synthesis during 
erythroid differentiation, we hypothesized that the inability to mobilize iron from 
ferritin storage could lead to inefficient erythopoiesis in NCOA4 -/- mice. Thus, 
we evaluated ematological parameters and red cell indices in NCOA4 null and 
WT mice under normal feeding condition.  
Interestingly, all KO mice had a significantly lower values of hematocrit and 
hemoglobin compared to WT, and small red blood cells with low hemoglobin 
content (MCV and MCH reduced) reflecting a condition of mild microcitic 
anemia (Table 1). 
Then, we decided to feed NCOA4 null and WT mice for five and seven months 
with an iron-low diet (2-3 mg/Kg) in order to force organism to release iron 
reserve to sustain erythropoiesis. 
We analyzed ferritin levels in livers of NCOA4 null and WT mice by western 
blotting after 5 months of low-iron diet (Fig. 8A). As expected, iron deprivation 
induced a complete depletion of ferritin in WT mice subjected to hypoferric diet 
with respect to normal diet whereas a significant amount of ferritin was still 
present in NCOA4 null mice.  
 Table 1.  
Hematological parameters and red cell indices in NCOA4+/+ and NCOA4 -/- mice 
under iron balance and iron deficient diets.  
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Notably, a slightly reduction of ferritin levels after low iron diet was also seen 
in KO animals, suggesting that NCOA4-independent process might promote iron 
release from ferritin in livers.  
The hypoferric diet efficiently induced mobilization of iron reserve in WT mice 
as demonstrated by maintenance of normal levels of transferrin saturation and 
serum iron in these animals whereas in KO animals circulating iron was 
significantly lower (Fig 8B). As a consequence of the greater iron need, in KO 
animals the hepcidin-ferroportin axis was completely suppressed. Indeed, as 
shown by real time analysis (Fig. 8C) liver Hepcidin expression was lower in 
NCOA4 deficient mice respect to WT animals, and, consequently, ferroportin 
was highly present in spleen macrophages as demonstrated by 
immunoistochemical analysis (Fig. 8D). 
All together, these data strongly confirmed the impairment of iron storage 
mobilization and recycling in NCOA4 null mice, also after a prolonged low iron 
diet. 
 
 
Figure 8. NCOA4 deficient mice display impaired iron mobilization under iron 
estricted diet feeding condition.  
A Western blot analysis of ferritin (FTH1) protein levels of WT and NCOA4 deficient mice 
under iron balance and iron deficient diets (5 months). Tubulin was used as loading control.  
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B Serum iron concentration and percentage of transferrin saturation were evaluated in NCOA4 
null and WT mice fed an iron deficient diet (5 months). Data are shown as a mean ± standard 
deviation. (*P<0.05) 
C Real time analysis RT-PCR of HAMP mRNA from livers of WT and NCOA4 mice fed an 
iron low diet for five months. Normalized data were expressed relative to the corresponding 
value for a WT control mice under iron deprivation.  
D Representative immunoistiochemical analysis of ferroportin (FPN) in spleen sections from 
NCOA4 WT and null mice fed an iron deficient diet (5 months). 
 
4.4 NCOA4 null mice display ineffective erythropoiesis and an impaired 
terminal erythroid differentiation under iron poor diet 
 
   Next, we decided to analyze erythropoiesis in iron deprivation conditions. As 
shown in the table, knock out animals after 5 months of low iron diet worsened 
their mild anemia displaying all red cell indices, such as MCV, MCH, MCHC, 
statistically decreased with respect to the WT. Moreover, null mice presented a 
lower number of reticulocytes in peripheral blood respect to the WT and an 
increased RDW (red cell distribution width), indicating that the small number of 
erythroid precursor able to complete differentiation had a variable size 
(anisocytosis; see also the representative staining of peripheral blood smear in 
Table 1). These analyses revealed a condition of severe hypochromic microcytic 
hyporegenerative anemia in NCOA4-/- mice that worsened after 7 months of 
low iron diet. Conversely, the WT mice developed a mild anemia after five 
months of diet, reaching a hyporegenerative anemia only after seven months of 
low iron diet.  
Then, to analyze in detail erythropoiesis, in collaboration with Professor Lucia 
De Franceschi from Verona University, we monitored terminal erythroid 
differentiation, by FACS analysis.  Terminal erythroid differentiation is a 
specific stage of erythropoiesis in which proerythroblast differentiates into 
morphologically distinct populations: basophilic, polychromatic and 
orthochromatic erythroblasts. This ordered process requires a decrease in cell 
size, chromatin condensation, hemoglobinization and a complete change in 
membrane protein composition. Thus, we discriminated and isolated 
erythroblast populations at each stage of development by flow citometry, 
analyzing the expression levels of TER119 (a molecule associated with 
glycophorin A, that specifically marks the late stages of murine erythroid 
lineage), CD44 (membrane adhesion molecule that decreased during terminal 
erythroid differentiation) and cell size (forward scatter parameter). 
As shown in Fig. 6A, the viable murine erythroblasts from bone marrow 
(impermeable to Propidium iodide and positive for Ter119) analyzed with 
respect to the expression levels of CD44 and forward scatter, separated five 
erythroid population: proerythroblasts (I), basophilic erythroblasts (II), 
polychromatic erythroblasts (III), orthochromatic erythroblasts and immature 
reticulocytes (IV) and mature red cells (V).  
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Under an iron balance diet, no significant difference were seen between WT and 
NCOA4 null mice differentiation (Fig. 6B). However, the erythropoiesis profile 
of bone marrow in KO mice was completely affected after five and seven months 
of iron deprivation, revealing a block in late stage of terminal differentiation (see 
IV population in Fig.6B). Indeed, the percentage of orthocromatic 
erythroblast/reticulocytes was significantly lower in NCOA4 null compared to 
WT mice after seven months of low iron diet (Fig.9C) and was associated to 
increased apoptosis, as demonstrated by analysis of Annexin V binding in IV 
population (Fig.9D).  
Overall, these data revealed that in NCOA4 KO mouse model the block of iron 
release (from hepatic storages) and iron recycle (from splenic macrophages) 
affects erythropoiesis, especially in iron depletion condition, when NCOA4 
mediated ferritinophagy seems to be crucial for the terminal erythroid 
differentiation.   
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Figure 9. Iron deficiency affects terminal erythroid differentiation in NCOA4 null 
mice 
A. Representative gating strategy for Ter119 subpopulation. Viable cells from bone marrow are 
impermeable to Propidium Iodide and are analyzed for Ter119 expression. Ter119 positive cells 
are further discriminated for CD44 surface expression and cell size parameter (FSC) in order to 
obtained distinct population.  
B. Flow citometry strategy explained in A combining CD44, Ter119 and FSC as markers to sort 
erythroid precursors from BM of  NCOA4 WT and null mice iron-repleted (untreated) or iron 
depleted diets ( five and seven months). 
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C. Percentage of erythroid precursors at each developmental stage sorted as in B. Errors bars 
indicate standard error. Asterisks refer to a statistically significant difference: *P<0.05. 
D. The survival of orthocromatic erythroblast was examined for annexin V binding to assess 
apoptosis.  
 
4.5 NCOA4-/- mice develop fatal liver damage under hyperferric diet 
 
   Given that NCOA4-/- mice were unable to degrade ferritin, accumulating a 
potential dangerous amount of iron, we examined the effect of iron overload in 
these animals when feeding a high-iron diet (1 g. After 15 days of high-iron diet, 
NCOA4 null mice continued to display higher hepatic levels of ferritin protein 
and higher hepatic iron content with respect to the WT (fig 10 A and 10 B). 
Since free iron can promote oxidative stress through Fenton reactions, we then 
focus our attention on the expression levels of antioxidant enzyme such as 
hepatic superoxide dismutase (SOD) and glutathione peroxidase (GPx). As 
shown in the graph (fig 10 C), real time analysis confirmed a higher expression 
of SOD and GPx genes in NCOA4 null mice compared to the WT. Although the 
activation of anti-oxidative defense in liver NCOA4 -/- mice, we found serum 
levels of the hepatic enzyme alanine and aspartate liver transferase (AST and 
ALT) significantly increased in null mice, reflecting a condition of liver damage 
(Fig 10 E). Consistently, after 1 month of hyperferric diet, hematoxylin and eosin 
staining of NCOA4 -/- liver sections showed a diffuse damage, with sign of a 
marked steatosis respect to the WT mice (Fig.10 D). Indeed, more numerous and 
bigger vacuoles in NCOA4 -/- sections, revealed pronounced fatty degeneration 
and impairment of normal cellular metabolism compared to WT liver sections. 
Finally, most NCOA4 mice started to die after 75 days of high iron diet and were 
all dead within 2 weeks after 100 days of diet, with a mean survival of 89 days. 
Notable, WT mice started to dye only after 100 days after hyperferric diet, with 
a mean survival of 104 days. Overall, these data demonstrated that NCOA4 null 
mice, displaying an iron tissue loading, were hypersensitive to iron rich diet and 
died prematurely respect to the WT mice.  
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Figure 10. NCOA4-/- mice develop fatal liver damage under hyperferric diet. 
A. Western blot analysis of FTH1 protein levels from livers of NCOA4 null and WT mice after 
15 days of high iron diet. Tubulin was used as loading control.  
B. Liver non-heme iron content of NCOA4 null and WT mice fed a high iron diet for 15 days. 
Data are mean values ± standard deviation from 4 independent sample. Asterisks refer to a 
statistically significant difference: *P<0.05. 
C. Real time RT-PCR analysis of superoxide dismutase (SOD) and glutathione peroxidase (GPx) 
mRNA expression of NCOA4 null and WT mice fed a high iron diet for a month. (*P <0.05) 
D. Representative histological analysis of NCOA4 null and WT mice liver sections stained with 
Hematoxylin and Eosin. The larger, white vesicles indicate droplets of fat.  
   34 
 
E. Serum levels of the hepatic enzyme alanine and aspartate liver transferase (AST and ALT) 
from NCOA4 null and WT mice after 1 month of high iron diet. AST and ALT levels were 
evaluated  from serum using a commercial Elisa Kit. 
F. Analysis of the fraction of 10 NCOA4 deficient mice and 10 NCOA4 WT mice surviving 
under high iron rich diet were represented by Kaplan-Meier survival curve. P value is indicated.  
 
4.6 NCOA4 protein controls ferritinophagy through its C-terminal portion  
 
   In order to characterize and identify the molecular determinants of NCOA4 
involved in ferritinophagy process, we performed an in vitro pull down-assay 
using HeLa cell protein extracts and recombinant full-length, N-terminal (1-238) 
or C-terminal (239-318) NCOA4 proteins fused to NusA tag. As shown in Fig. 
8A, both Nus-NCOA4 and (C)-NCOA4 were able to pull down the heavy chain 
of ferritin (FTH1). On the contrary, no signal was detected in pull down 
experiments with (N)-NCOA4 or Nus moiety alone. Then, in order to evaluate 
which portion of NCOA4 is involved in the specific binding to autophagosome-
associated proteins, such as GABARAP and GABARAPL1, we performed 
another pull down using, as a bait, recombinant protein GABARAP, 
GABARAPL1 and LC3B fused to GST. HEK293T cells, transiently expressing 
MYC-tagged NCOA4, HA-tagged NCOA4 (N) and NCOA4 (C) protein, were 
used as protein source (Fig. 11B e 11C). Again, as for ferritin, NCOA4 full 
length and the C-terminal portion of NCOA4 were also purified from 
GABARAP and GABARAPL1 recombinant proteins whereas no interaction 
was detected for LC3B recombinant protein. 
 
Figure 11. NCOA4 C-terminal is involved in ferritin and ATG8-like protein 
binding 
A. NUS, NUS NCOA4 (N), NUS NCOA4 (C) and full length NUS NCOA4 were used as bait 
recombinant proteins immobilized on resin and incubated with protein extracts from Hela cells. 
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The pulled down ferritin was analyzed by western blotting. The filter was colored with ponceau 
staining to visualize the input of recombinant proteins. 
B. and C. GST alone or GST- tagged GABARAP, GABARAP-L1 and LC3B recombinant 
protein immobilized on resin were incubated with protein extracts from 293T cells transiently 
transfected with Myc-NCOA4, Ha-tagged NCOA4(N) or (C) encoding vector. The pulled-down 
proteins were analyzed by western blotting.  
 
Since the C-terminal portion of NCOA4 was sufficient for  ferritin and ATG8-
like protein binding, we asked whether NCOA4 (C) portion alone could sustain 
ferritin degradation. We used Mouse Embryonic Fibroblasts (MEF) derived 
from NCOA4 deficient and wild type mice and firstly, verified the ferritinophagy 
process. As expected, NCOA4 null MEFs displayed higher levels of Ferritin 
protein respect to the WT at basal conditions, with no significant changes in iron 
labile pool as demonstrated by similar IRP2 proteins levels (Fig.12A). Then, we 
monitored ferritin degradation in NCOA4 null and WT MEFs. We first cultured 
fibroblasts in the presence of Ferric Ammonium Citrate (FAC) for 16 hours in 
order to induce iron accumulation into ferritin and then we treated cells for 
increasing time with the iron chelator Deferoxamine to promote iron 
mobilization from storage. Western blot analysis revealed that ferritin was 
rapidly degraded in WT MEFs and began undetectable after 6 hours of DFO 
treatment. Differently, more than 50% of ferritin was present after 9 hours of 
DFO in NCOA4 -/- MEFs reflecting a slower kinetic of degradation (Fig.12B). 
We finally evaluated whether, in NCOA4 null MEFs the isolated C-terminal 
portion of NCOA4 allowed ferritin degradation in response to iron depletion. 
We infected NCOA4 null MEFs with retrovirus expressing full length, C-
terminal or N-terminal fragments of NCOA4 and analyzed ferritin content after 
FAC/DFO release treatments. As shown in Fig. 12C, the (C)-terminal fragment 
of NCOA4 was able to induce ferritin turnover in low iron condition similarly to 
the full-length protein. On the contrary, MEFs infected with (N)-NCOA4 
fragment displayed impaired ferritin digestion as the null MEFs. Altogether, 
these experiments showed that NCOA4 protein controls ferritin delivery to 
autophagosomes to induce iron release using its C-terminal domain, which is 
distinct from the one necessary to interact with MCM2-7 complex and control 
DNA replication. 
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Figure 12. The C-terminal portion of NCOA4 protein is sufficient to allow ferritin 
degradation  
A. Western blot analysis with the indicated antibody of protein extracts from immortalized 
Mouse Embryonic Fibroblasts derived from NCOA4 null and WT mice. The asterisk indicated 
an unspecific band.  
B. Western blot analysis of NCOA4 and Ferritin proteins in NCOA4 null and WT MEFs 
subjected to iron depletion. MEFs were first incubated o/n with FAC to allow ferritin 
accumulation and then release in medium containing the iron chelator DFO and harvested at the 
indicated time point.  
C. NCOA4 null MEFs were infected with retrovirus expressing full length, C-terminal or N-
terminal NCOA4 vector or an empty vector (pBABE), then subjected to FAC/DFO treatment as 
in B to verify ferritin degradation.  
 
4.8 Iron bioavailability affects intracellular NCOA4 levels and cell cycle 
progression    
 
      Besides ferritinophagy, it has been already demonstrated that NCOA4 
protein exerts a negative control over DNA replication. Since iron levels affect 
cell cycle progression inducing a DNA replication arrest (Le N. et al, 2002), we 
sought to verify whether, in response to iron bioavailability, NCOA4 could 
regulate/inhibit DNA origins activation.  
We initially studied NCOA4 and ferritin levels during cell cycle, upon 
subcellular fractionation of HeLa cells and analysis of the soluble fraction 
(cytosol and nucleoplasm) and the insoluble fraction (chromatin). During early-
mid G1 phase (2-6 hours after Nocodazole release) NCOA4 increased in 
insoluble fraction (figure 13 A),   reaching a peak prior to the onset of the S-
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phase, which occurs after 8-10 hours as shown by Cyclin E protein peaking. 
Soon after, when PCNA became detectable onto chromatin to allow processive 
polymerases activity and thus, DNA replication, chromatin-bound NCOA4 
protein levels started to decrease. Ferritin protein was detected only in soluble 
fraction and its levels interestingly decreased in S-phase when cytosolic NCOA4 
was stabilized and could mediate ferritinophagy, supporting the idea that the 
progression through G1 phase towards S phase requires appropriate iron levels, 
firstly necessary for dNTP synthesis. Indeed, depletion of iron using 
Deferoxamine for 8 and 16 hours in asynchronous HeLa cells affected cell cycle 
distribution, enriching cells with a G1-phase DNA content (2n) (from 74,4% to 
88,4% of cells in G1 phase after 16 h of DFO) and reducing the S-phase 
population (from 9,7 to 5,1% of cells in S-phase), as shown by flow citometry 
profile in Fig.10B.  
At molecular level, increased incubation with DFO induced a stabilization of 
NCOA4 cytosolic levels that soon accumulated in order to promote ferritin 
degradation via autophagy, as demonstrated by western blotting analysis (Fig 13 
C, cytosol fraction). Moreover, after 2 hours of iron chelator treatment, NCOA4 
levels also increased in nucleosol (Fig13 C), strongly enriching its loading onto 
chromatin (Fig.13 D, insoluble fraction).  
 
 
 
Figure 13. Iron bioavailability affects cell cycle progression and  intracellular 
NCOA4 levels. 
A. HeLa cells released from Nocodazole arrest were harvested at the indicated time points (h). 
Sychronized cells were then subjected to subcellular fractionation in order to obtain a soluble 
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fraction (cytosol and nucleosol) and an unsoluble fraction (chromatin-bound protein) and 
analyzed by western blotting using the indicated antibody. Histon 3 and Tubulin were used as 
fractionation control. 
B. Asyncronous HeLa cells were treated with 50 uM Deferoxamine (DFO) for 8 and 16 hours, 
stained with Propidium Iodide and analized using flow citometry. Cell cycle profiles of 
processed cells were shown and percentage of cells in each phase were reported as bar graph. 
C. Asyncronous HeLa cells were treated with 50 uM DFO and harvested at the indicated time 
points. Cells were then subjected to cytosol/nucleosol fractionation (using NePer kit) and 
analized by Western blotting. 
D. HeLa cells were treated with DFO as in C. Samples were subjected to biochemical 
fractionation obtaining a soluble (cytosol and nucleosol) and an unsoluble fraction (chromatin-
bound protein), then analyzed by western blotting with different antibodies. 
 
 To exclude that the NCOA4-enrichment in chromatin fraction was an indirect 
effect of the iron-dependent G1-cell cycle arrest and a consequent blockage of 
DNA origins activation (failure of NCOA4 release from replisome), we 
monitored chromatin-bound and soluble proteins depleting iron specifically in 
G1-phase or in S-phase of the cell cycle. We synchronized HeLa cells in M-
phase with Nocodazole (an inhibitor of microtubule polymerization) then release 
cells in complete medium to allow cycle re-entry and treated or not cells with 
DFO in early G1 phase (2 h after Nocodazole release) (Fig 14 A). As expected, 
under normal condition, western blotting analysis of chromatin fraction proteins 
revealed a reduction of NCOA4 levels in S-phase (8-14 hours after Nocodazole 
release) whereas PCNA levels increased and DNA replication progressed. Iron 
depletion in early G1 phase blocked S-phase progression, as demonstrated by 
the lower levels of cyclin E and the almost undetectable levels of PCNA onto 
chromatin. In addition, we also found Chk1, a kinase effector of the DNA 
Damage Response activated, as demonstrated by the increased phosphorylation 
status of ChK1 in response to iron chelation (Fig. 14 A, lower panel), confirming 
the activation of the replication checkpoint due to decrease levels of iron (IDR, 
Iron Deficiency Response). Consistently, NCOA4 remained stable onto 
chromatin for hours after DFO treatment, reaching even higher levels onto 
chromatin in comparison to the untreated cells (Fig.11 A bottom panel and B see 
quantification of chromatin bound NCOA4).  
Then, we depleted iron from cells during S-phase (at 8 hours from Nocodazole 
release), when many DNA origins had already fired and NCOA4 chromatin 
bound was reduced (Fig 14 C). Again, iron chelation affected cell cycle 
progression, as demonstrated by the lower levels of cyclin B and the stabilized 
levels of cyclin E compared to the untreated cells (Fig.14 C, top panel.) 
Surprisingly, iron depletion also induced a significant increase in NCOA4 
loading onto chromatin (Fig 14, bottom panel) whereas PCNA levels 
immediately decreased, indicating a blockage of further DNA replication origins 
activation. Taken together, these data indicated that NCOA4 responded to iron 
depletion, increasing its protein levels in both cytosol and nuclear fraction. 
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Figure 14. NCOA4 increases the binding to chromatin in iron depletion  
A. HeLa cells  were treated with Deferoxamine (DFO) 2 hours after Nocodazole release (in early 
G1 phase) and then were harvested at the indicated time points (h). Soluble (cytosol and 
nucleosol) and insoluble (chromatin-bound) extracts were subjected to western blotting analysis 
using the indicated antibodies. 
B. Densitometric analysis of normalized, Chromatin-bound NCOA4 of the insoluble fraction of 
A was performed using ImageQuant. Data are shown as a mean ± SD of two independent 
experiments. 
C. HeLa cells  were treated with Deferoxamine (DFO) 8 hours later Nocodazole release (in S-
Phase), then were harvested at the indicated time points (h). Soluble (cytosol and nucleosol) and 
insoluble (chromatin-bound) extracts were subjected to western blotting analysis using the 
indicated antibodies.  
D. Densitometric analysis of normalized, Chromatin-bound NCOA4 of the insoluble fraction of 
C was performed using ImageQuant. Data are shown as a mean ± SD of two independent 
experiments 
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4.9 NCOA4 is enriched at DNA replication origins in response to iron 
depletion 
 
     We next sought to determine the biological significance of the iron dependent 
enrichment of nuclear NCOA4. Because NCOA4 exerts a negative regulation 
over DNA synthesis during cell cycle, interfering with DNA helicase by a direct 
interaction with MCM7, we hypothesized that iron depletion could control DNA 
origins activation through NCOA4 activity on MCM2-7.  
First, we evaluated NCOA4 interaction with MCM7 in normal and iron depleted 
condition by coimmunoprecipitation assay. As shown in figure 15 A, MCM7 
immunoprecipitated from chromatin together with NCOA4 and after 2 hours of 
iron depletion, this interaction increased.  
Furthermore, we tested the enrichment of NCOA4 after DFO treatment at known 
canonical replication origins, mapped close to Myc and Lamin B2 genes, by 
Chromatin immunoprecipitation (ChIP) analysis. As shown in the graph, 
NCOA4 preferentially bound near origin regions (Fig. 15 B e C) with respect to 
distant, control regions. After iron chelation, NCOA4 binding to replication 
origins increased of 2 and 3 fold with respect to the control region, in myc and 
lamin B2 origins respectively.  
The data obtained revealed a stronger NCOA4 binding to DNA origins via 
presumably  its MCM7-interactor in iron depletion.  
 
 
Figure 15. NCOA4 enrichment at canonical DNA replication origins in iron 
depletion 
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A. Total Protein extracts from asynchronous HeLa cells treated with Deferoxamine (DFO), were 
subjected to immunoprecipitation with αNCOA4 and immunoblotted with the indicated 
antibodies. 
B. and C Chromatin immunoprecipitation on human myc and lamin B2 loci was performed using 
anti-NCOA4. On the left, bar graphs showed fold enrichment of NCOA4 at Origin region with 
respect to control region precipitated with NCOA4 antibody from ChIP experiments. On the 
right, schematic representation of genomic Myc and Lamin B2 loci together with PCR fragments 
and primer sets (converging arrows) used for quantitative real-time PCR analysis. Each 
amplified region span respectively 5.8 and 4 Kb around the described loci. Results are shown as 
means of duplicates +/- SD.  
 
4.10 NCOA4 mediates DNA replication arrest during iron depletion 
 
   Finally, we sought to verify whether NCOA4 mediates DNA replication arrest 
during iron depletion monitoring DNA replication in transiently silenced HeLa 
cell lines.  
After synchronization of control and silenced cells, we depleted iron during S-
phase (at 8 hours from Nocodazole release) and monitored protein levels in 
chromatin fraction by western blotting (Fig. 16 A). As already mentioned, in 
control cells, NCOA4 and PCNA-chromatin bound were inversely related in 
normal and iron depleted condition, with the increase of PCNA levels and the 
opposite decrease of NCOA4 as long as replication progressed. To note, in 
silenced cells the expression of NCOA4 was not completely abrogated and 
NCOA4 levels in chromatin fraction became detectable after iron depletion. 
Interestingly, after DFO treatment, PCNA levels in NCOA4 silenced cells were 
higher compared to the control cells, suggesting that numerous origins continued 
to fire despite iron depletion. Moreover, this unscheduled origins activation in 
NCOA4 deficient cells promoted replication stress, strongly activating the DNA 
damage response as demonstrated by phosphorylation of Chk1 protein. The 
improper DNA replication of NCOA4 depleted cells under iron depleted 
condition was also confirmed by the higher and significant BrdU incorporation 
in silenced cells compared to control cells after 2 hours of DFO treatment (Fig. 
16 B and C) as demonstrated by FACS analysis and confocal microscopy. 
Based on these results, we concluded that reduction of NCOA4 activity affected 
the DNA replication arrest activated by iron depletion, promoting uncontrolled 
DNA origin firing, replication stress and the consequent activation of DNA 
damage response. 
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Figure 16. The iron-dependent arrest of DNA replication fails in NCOA4-silenced 
cells   
A. HeLa cells were transfected with shNCOA4 or SH control for 48 hours then were 
synchronized in G2/M transition with Nocodazole; 8 hours later Nocodazole release (in S-Phase) 
cells were treated with Deferoxamine (DFO), then harvested at the indicated time points (h). 
Soluble (cytosol and nucleosol) and insoluble (chromatin-bound) extracts were subjected to 
western blotting analysis using the indicated antibodies. 
B. Bar graph showing the relative BrdU (halogenated nucleotide) incorporation of NCOA4 
silenced and control HeLa cells in normal (NT) and iron depleted (DFO) condition. Cells were 
release from Nocodazole block and treated with DFO in S-phase (8 hours) for 2 hours. 
Halogenated nucleotides was added for 30 minutes. Mean values ± standard deviation of 2 
experiments are represented. 
C. Representative Fluorescence image of NCOA4 silenced and control cells after DFO treatment 
as described in B. 
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 5 DISCUSSION 
 
NCOA4 is a novel player in cellular iron metabolism. It is an iron sensing protein 
that, in iron depleted condition, accumulates, avoiding the HERC2-dependent 
proteosomal degradation, and promotes, via its c-terminal portion, the 
autophagic degradation of ferritin (the ferritinophagy process) in order to restore 
appropriate iron levels. We have explored the impact of ferritinophagy at 
systemic level using a mouse model carrying total genetic ablation of NCOA4 
gene. In addition, we have explored the role of NCOA4 in controlling DNA 
replication in relation to iron metabolism in order to couple these diverse 
functions of the protein.  
NCOA4 absence leads to ferritin accumulation in several key organs involved in 
iron metabolism of NCOA4 null mice, such as duodenum, liver and spleen. 
NCOA4 null mice also display higher transferrin saturation and serum ferritin 
respect to the WT mice, reflecting the tissue iron loading. As response of highest 
TfR saturation, in NCOA4 null mice liver hepcidin expression increases in order 
to reduce duodenal iron absorption via ferroportin degradation and limits, as a 
compensating mechanism, dangerous iron overload. However, although the 
activated Hepcidin-ferroportin regulatory circuit, NCOA4 null mice died 
prematurely when fed an iron rich diet showing signs of liver damage. The 
increased basal levels of ferritin in NCOA4 null mice probably deplete earlier 
the antioxidant defense with respect to control mice, making these mice 
hypersensitive to iron overload. Notably, NCOA4 deficient mice represent a 
peculiar case of hemochromatosis because tissue iron overload occurs in the 
contest of a functional Hepcidin-mediated response.   
Despite tissue iron loading, NCOA4 null mice suffer anemia with reduced 
hemoglobin and microcytic erythrocytes (low MCH and MCV), resembling an 
iron deficient anemia. Under iron-restricted diet, NCOA4 null mice were unable 
to mobilize iron reserve from ferritin and worsened their condition, developing 
a severe hypochromic microcytic anemia and ineffective erythropoiesis, as 
demonstrated by the impaired terminal erythroid differentiation and apoptosis of 
orthoblastic population. Interestingly, NCOA4 has been already identified 
among the highest expressed gene during terminal erythroid differentiation, 
especially in orthocromatic erythroblasts (Gallegher et al, 2014). Therefore, 
NCOA4-mediated ferritinophagy seems to be crucial for hemoglobinization and 
the correct development of erythroblasts.  
Besides controlling ferritinophagy, NCOA4 exerts a negative control over DNA 
replication. Indeed, during cell cycle, nuclear NCOA4 binds to replisome, 
through a direct interaction with a member of the DNA helicase, MCM7, and 
blocks DNA origins activation. At the onset of S-phase, NCOA4 reduces its 
binding to chromatin allowing DNA replication whereas cytosolic NCOA4 is 
stabilized and, interestingly, ferritin levels decreased, probably to release iron 
and sustain iron needs during S-phase. 
Many proteins, playing key role in DNA metabolism utilize iron as cofactor. As 
fundamental microelement, disruption of iron homeostasis by chelators impairs 
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normal cell cycle progression and evokes a complex signaling causing a G1-
arrest, which can be referred to as IDR, iron depletion response. NCOA4 is also 
affected by iron bioavalaibility, acting as an effector of this iron sensitive 
checkpoint. Indeed, in a cell cycle independent manner NCOA4 responds to low 
iron, translocating into the nucleus and increasing its binding to replisome, via 
MCM7. The finding that nuclear NCOA4 is enriched at canonical DNA 
replication origins loci when iron levels are low, suggest that NCOA4, by 
controlling DNA helicase, could avoid dangerous origins firing and prevent 
DNA synthesis when no sufficient resources are available to complete the 
process. However, nuclear NCOA4 senses iron also when replication has started 
and many origins have already fired, increasing its loading onto chromatin. In 
these circumstances, iron depletions could affect DNA synthesis, slowing and 
stalling DNA replication forks and could activate the DNA damage checkpoint 
responsible for the inhibition of further origin firing (Diffley et al, 2013). Thus, 
NCOA4 could participate also in this signaling and block late origins firing 
maintaining its binding to pre-RC.  
The iron-dependent blockage of DNA replication fails in absence of NCOA4 
and DNA origins continue to fire although iron depletion, as demonstrated by 
the persistent incorporation of halogenated nucleotides and the higher levels of 
PCNA in NCOA4 silenced cell respect to control. However, the simultaneous 
and uncontrolled origins activation in NCOA4-silenced cells is likely to 
depauperate nucleotides and replication factors in iron depletion leading to 
replication stress and probably to a permanent cell cycle blockage-senescence as 
observed when replication is promoted by oncogene activation (OIS). Our data 
indicate NCOA4 as a unique iron-sensing protein able to correlate DNA 
replication with iron levels. In low iron condition, NCOA4 inhibits DNA origins 
activation to avoid replication stress as well as contributes to restore the 
appropriate iron levels promoting ferritinophagy. Its ablation affects this iron-
dependent checkpoint and probably impairs cell proliferation. Thus, we can not 
exclude that the impairment of erythropoiesis in NCOA4 null mice could be, at 
least in part dependent on the alteration of NCOA4 nuclear function. 
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6 CONCLUSIONS  
 
Intracellular iron levels are tightly controlled to sustain crucial cellular processes 
such as DNA synthesis and repair as well as to avoid the iron-dependent toxic 
effects. Iron deficiency is not tolerated and cells have evolved complex 
responses to block cellular growth until iron levels are restored, a checkpoint 
response that we named IDR, Iron Depletion Response.  
Here we report that NCOA4 is a novel key iron responsive protein, able to 
correlate iron bioavailability to cellular proliferation. NCOA4 accumulates when 
iron levels lowers in order to promote iron release from ferritin storage and to 
block DNA replication origins firing, avoiding replication stress. NCOA4 
regulatory role provides the direct connection between DNA metabolism and 
iron homeostasis and indicates NCOA4 as en effector of the IDR.  
Further analysis are needed to reveal the signaling pathways responsible for 
NCOA4 nuclear localization under iron depletion. It remains to be clarify 
whether NCOA4 regulates late firing origin under iron depletion condition, 
participating to the global checkpoint-dependent inhibition of origin activation 
as response to replication stress. Moreover, it should be investigating whether 
NCOA4-modulation of MCM2-7 helicase occurs at replication bubble as well to 
prevent forks collapse upon stalling because of iron depletion. Finally, it will be 
interesting define and map the genomic region where NCOA4 binds in response 
to iron depletion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   46 
 
REFERENCES 
 
 
An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. 
Stabilization of wild‑type p53 by hypoxia‑inducible factor 1alpha. Nature 1998; 
392:405‑8. 
Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69-85. 
Review. 
Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, 
Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A 
and Santoro M. Potent Mitogenicity of the RET/PTC3 Oncogene Correlates with 
Its Prevalence in Tall-Cell Variant of Papillary Thyroid Carcinoma. American 
Journal Of Pathology, 02/2002; 160(1):247-54. 
Bianchi L, Tacchini L, Cairo G. HIF‑1‑mediated activation of transferrin 
receptor gene 
Brissot P, Ropert M, Le Lan C, Loréal O. Non-transferrin bound iron: a key role 
in iron overload and iron toxicity. Biochim Biophys Acta. 2012 Mar;  
Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is 
induced by hypoxia. Proc Nat Acad Sci USA 2000; 97:9082‑7 
Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, Triantafellow E, Menon S, 
Wang Z, Honda A, Pardee G, Cantwell J, Luu C, Cornella-Taracido I, 
Harrington E,  Fekkes P, Lei H, Fang Q, Digan ME, Burdick D, Powers AF, 
Helliwell SB, D'Aquin S, Bastien J, Wang H, Wiederschain D, Kuerth J, 
Bergman P, Schwalb D, Thomas J, Ugwonali S, Harbinski F, Tallarico J, Wilson 
CJ, Myer VE, Porter JA, Bussiere DE, Finan PM, Labow MA, Mao X, Hamann 
LG, Manning BD, Valdez RA, Nicholson T, Schirle M, Knapp MS, Keaney EP, 
Murphy LO. Selective VPS34 inhibitor blocks autophagy and uncovers a role 
for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol. 
2014 Nov;16(11):1069-79. 
Farzaneh F, Hediger MA, Hentze MW, Simpson RJ. A novel duodenal iron-
regulated transporter, IREG1, implicated in the basolateral transfer of iron to the 
circulation. Mol Cell. 2000 Feb;5(2):299-309. 
Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, 
Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC. The 
hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin 
interaction and cell surface expression. J Biol Chem. 1997 May 
30;272(22):14025-8. 
Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and 
the role of transferrin. Biochim Biophys Acta. 2012 Mar; 1820(3):188-202.  
Gozzelino R, Arosio P. Iron Homeostasis in Health and Disease. Int J Mol  Sci. 
2016 Jan 20;17(1).  
Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, 
Nussberger S, Gollan JL, Hediger MA. Cloning and characterization of a 
mammalian proton-coupled metal-ion transporter. Nature. 1997 Jul 31 
   47 
 
Hartwell, L.H., Weinert, T.A., 1989. Checkpoints: controls that ensure the order 
of cell cycle events. Science 246, 629/634. 
Hediger MA. Cloning and characterization of a mammalian proton-coupled 
metal-ion transporter. Nature. 1997 Jul 31;388(6641):482-8. 
Heinlein CA1, Ting HJ, Yeh S, Chang C. Identification of ARA70 as a ligand-
enhanced coactivator for the peroxisome proliferator-activated receptor gamma. 
J Biol Chem. 1999 Jun 4;274(23):16147-52. 
Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: 
regulation of Mammalian iron metabolism. Cell. 2010 Jul 9;142 (1):24-38. 
Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of 
erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014 
Jul;46(7):678-84. 
Kollara A, Kahn HJ, Marks A, Brown TJ.Loss of androgen receptor associated 
protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. 
Breast Cancer Res Treat. 2001 Jun;67(3):245-53. 
Krause, A., Neitz, S., Magert, H.J., Schulz, A., Forssmann, W.G., Schulz-
Knappe, P. and Adermann, K. LEAP-1, a novel highly disulfide-bonded human 
peptide, exhibits antimicrobial activity. FEBS Lett. 480, 147–150 (2000) 
Kwok JC, Richardson DR. The iron metabolism of neoplastic cells: alterations 
that facilitate proliferation? Crit Rev Oncol Hematol. 2002 Apr;42(1):65-78. 
Lakhal S1, Schödel J, Townsend AR, Pugh CW, Ratcliffe PJ, Mole DR. (2011) 
Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-
inducible factors: new link between hypoxia signaling and iron homeostasis. J 
Biol Chem. 11;286(6):4090-7. doi: 10.1074/jbc.M110.173096.  
Le NT, Richardson DR. The role of iron in cell cycle progression and the 
proliferation of neoplastic cells. Biochim Biophys Acta. 2002. Review.  
Le Rolle A, Klempner S, Garrett C, Seery T, Sanford E, Balasubramanian S, 
Ross J, Stephens P, Miller V, Ali S and Chiu V. Identification and 
characterization of RET fusions in advanced colorectal cancer. Oncotarget. 2015 
Oct 6; 6(30): 28929–28937. 
Liuzzi JP, Aydemir F, Nam H, Knutson MD, Cousins RJ. Zip14 (Slc39a14) 
mediates non-transferrin-bound iron uptake into cells. Proc Natl Acad Sci U S 
A. 2006 Sep  12;103(37):13612-7. Epub 2006 Sep 1. 
Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC. Quantitative 
proteomics  identifies NCOA4 as the cargo receptor mediating ferritinophagy. 
Nature. 2014 May 1;509(7498):105-9 
McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, 
Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, Simpson RJ. A 
novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral 
transfer of iron to the circulation. Mol Cell. 2000 Feb 
McKie, A.T The role of Dcytb in iron metabolism: an update. 2008 Biochem. 
Soc. Trans. 36, 1239–1241. 
Moore JM, Galicia SJ, McReynolds AC, Nguyen NH, Scanlan TS, Guy RK. 
Quantitative proteomics of the thyroid hormone receptor-coregulator 
interactions. J Biol Chem. 2004 Jun 25;279(26):27584-90. Epub 2004 Apr 19. 
   48 
 
Moroishi T1, Nishiyama M, Takeda Y, Iwai K, Nakayama KI. The FBXL5-IRP2 
axis is integral to control of iron metabolism in vivo. Cell Metab. 2011 Sep 
7;14(3):339-51.  
Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, 
D.M., Ganz, T., and Kaplan, J. Hepcidin regulates cellular iron efflux by binding 
to ferroportin and inducing its internalization. Science 306, 2090–2093. 2004 
Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L. Mechanisms of 
mammalian iron homeostasis. Biochemistry. 2012 Jul 24 2012 Jul 9. 
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P. and 
Loreal, O. A new mouse liver-specific gene, encoding a protein homologous to 
human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. 
Biol. Chem. 276, 7811–7819 (2001) 
Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. 2008 
The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by 
cleaving membrane hemojuvelin. Cell Metab. (6):502-11.  
Surguladze N, Patton S, Cozzi A, Fried MG, Connor JR. Characterization of 
nuclear ferritin and mechanism of translocation. Biochem J. 2005 Jun 15;388 (Pt 
3):731-40. 
Taher AT, Musallam KM, Inati A. Iron overload: consequences, assessment, and 
monitoring. Hemoglobin. 2009; 33 Suppl 1:S46-57 
Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei 
Y, Nakamura Y. A ribonucleotide reductase gene involved in a p53‑dependent 
cell‑cycle checkpoint for DNA damage. Nature 2000; 404:42‑9. 
Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, Bhupatiraju A, Lee YT, 
Goodnough JB, Harandi O, Ganz T, Paulson RF, Miller JL. Identification of 
TWSG1 as a second novel erythroid regulator of hepcidin expression in murine 
and human cells. Blood. 2009 Jul 2;114(1):181-6.  
Tekur S, Lau KM, Long J, Burnstein K, Ho SM. Expression of 
RFG/ELE1alpha/ARA70 in normal and malignant prostatic epithelial cell 
cultures and lines: regulation by methylation and sex steroids. Mol Carcinog. 
2001 Jan;30(1):1-13 
Tomas Ganz J Macrophages and systemic iron homeostasis Innate Immun. 
2012;4(5-6):446-53.  
Wang R, Hu H, Pan Y, Li Y, Ye T, Li C, Luo X, Wang L, Li H, Zhang Y, Li F, 
Lu Y, Lu Q, Xu J, Garfield D, Shen L, Ji H, Pao W, Sun Y and Chen H. RET 
Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non–
Small-Cell Lung Cancer. Journal of Clinical Oncology 2012. doi: 
10.1200/JCO.2012.45.8240 
Wilkinson N, Pantopoulos K. The IRP/IRE system in vivo: insights from mouse 
models. Front Pharmacol. 2014 Jul 28; 2014. 
Zhang C. Essential functions of iron-requiring proteins in DNA replication, 
repair and cell cycle control. Protein Cell. 2014 Oct;5(10):750-60.  
Zhao N1, Zhang AS, Enns CA. Iron regulation by hepcidin. J Clin Invest. 2013 
Jun 3;123(6):2337-43. 
 
   49 
 
 
 
ReportNCOA4 Deﬁciency Impairs Systemic Iron
Homeostasis
Graphical AbstractHighlights
d Genetic disruption of NCOA4 causes ferritin accumulation in
tissues
d NCOA4 deﬁciency blocks iron mobilization from ferritin
storage and induces anemia
d NCOA4-nul mice are hypersensitive to iron overloadBeleli et al., 2016, Cel Reports14, 411–421
January 26, 2016ª2016 The Authors
htp://dx.doi.org/10.1016/j.celrep.2015.12.065Authors
Roberto Beleli, Giorgia Federico,
Alessandro Mate’, .., Massimo Santoro,
Lucia De Franceschi,
Francesca Carlomagno
Correspondence
francesca.carlomagno@unina.it
In Brief
NCOA4 is crucial for autophagic ferritin
degradation. Beleli et al. ﬁnd that genetic
disruption of NCOA4 causes ferritin
accumulation in tissues and defective
iron mobilization from storage. NCOA4-
nul mice display impaired erythropoiesis
associated with microcytic and
hypochromic anemia, which is more
pronounced in mice fed an iron-depleted
diet.
Cel ReportsReport
NCOA4 Deﬁciency Impairs Systemic Iron Homeostasis
Roberto Beleli,1,5Giorgia Federico,1Alessandro Mate’,2David Colecchia,3Achile Iolascon,1,4Mario Chiarielo,3
Massimo Santoro,1Lucia De Franceschi,2and Francesca Carlomagno1,*
1Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universita`degli Studi di Napoli Federico I, and Istituto di Endocrinologia ed
Oncologia Sperimentale del Consiglio Nazionale dele Ricerche, 80131 Napoli, Italy
2Dipartimento di Medicina, Universita`degli Studi di Verona–Azienda Ospedaliera Universitaria Integrata Verona, 37134 Verona, Italy
3Istituto Toscano Tumori-Core Research Laboratory and Consiglio Nazionale dele Ricerche–Istituto di Fisiologia Clinica, 53100 Siena, Italy
4Centro di Ingegneria Genetica Advanced Biotechnologies, 80145 Naples, Italy
5Present address: DNA Damage Response Laboratory, Clare Hal Laboratory, The Francis Crick Institute, South Mimms EN6 3LD, UK
*Corespondence:francesca.carlomagno@unina.it
htp:/dx.doi.org/10.1016/j.celrep.2015.12.065
This is an open access article under the CC BY-NC-ND license (htp:/creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
The cargo receptor NCOA4 mediates autophagic
ferritin degradation. Here we show that NCOA4 deﬁ-
ciency in a knockout mouse model causes iron accu-
mulation in the liver and spleen, increased levels of
transferrin saturation, serum ferritin, and liver hepci-
din, and decreased levels of duodenal ferroportin.
Despite signs of iron overload, NCOA4-nul mice
had mild microcytic hypochromic anemia. Under an
iron-deprived diet (2–3 mg/kg), mice failed to release
iron from ferritin storage and developed severe
microcytic hypochromic anemia and inefective ery-
thropoiesis associated with increased erythropoietin
levels. When fed an iron-enriched diet (2 g/kg),
mice died prematurely and showed signs of liver
damage. Ferritin accumulated in primary embryonic
ﬁbroblasts from NCOA4-nul mice consequent to
impaired autophagic targeting. Adoptive expression
of the NCOA4 COOH terminus (aa 239–614) restored
this function. In conclusion, NCOA4 prevents iron
accumulation and ensures efﬁcient erythropoiesis,
playing a central role in balancing iron levels in vivo.
INTRODUCTION
Iron is essential for oxygen transport, oxidation-reduction reac-
tions, and metabolite synthesis (Andrews and Schmidt, 2007;
Ganz and Nemeth, 2012). However, because of its high chemical
reactivity and ability to generate reactive hydroxyl radicals
through Fenton chemistry, iron concentration must be tightly
controled in tissues, cels, and blood (Papanikolaou and Panto-
poulos, 2005). Notably, iron is stored in transport (transferin) or
deposit (feritin) protein complexes to protect it from the delete-
rious efects of Fenton reactions. Feritin is a ubiquitously ex-
pressed cytosolic multimeric protein complex constituted of 24
H- and L-polypeptide subunits that self-organize in diferent ra-
tios in a tissue-dependent fashion and form a shel-like nanocage
in which iron is stored. Each ‘cage’ accommodates up to 4,500
iron atoms in the Fe(II) state (Arosio et al., 2009). Iron concentra-Cetion in mammals is mainly regulated by a set of interlocking reg-
ulatory circuits involving hepcidin, hypoxia-inducible factor 2a
(HIF2a), and iron regulatory proteins (IRPs) (Hentze et al., 2010).
Serum and tissue iron levels are principaly regulated by
iron absorption. Dietary heme iron is absorbed efﬁciently via
membrane transport mechanisms that have yet to be fuly char-
acterized. Non-heme iron is transported into enterocytes by the
divalent metal transporter 1 (DMT1), which is the apical trans-
porter of iron ions. Most of the iron taken up is stored in feritin
and lost upon sloughing of senescent enterocytes. The basolat-
eral transporter feroportin (FNP) caries iron from enterocytes to
the blood. Transferin then transports iron to peripheral tissues
via a receptor-mediated uptake process. Two transferin recep-
tors have been identiﬁed: a high-afﬁnity, widely expressed re-
ceptor, transferin receptor 1 (TfR1), which is required for celular
iron uptake, and a bone marow/liver-speciﬁc low-afﬁnity recep-
tor, TfR2, which is mainly involved in the regulation of iron ho-
meostasis in the liver and bone marow (Nai et al., 2015).
The main hormone regulating intestinal iron uptake and re-
lease from splenic macrophages is hepcidin, whose production
in the liver is controled by serum iron concentrations, erythropoi-
esis, and inﬂammation. By promoting internalization and ubiqui-
tin-mediated degradation of the iron transporter feroportin l
(Fnp1), hepcidin reduces iron absorption and its recycling from
red blood cel breakdown. Hepcidin expression is regulated by
systemic iron availability. Therefore, a high concentration of
Fe(II)-saturated transferin activates the TfR2 receptor in com-
plex with the HFE (High Iron Fe) protein, which, in turn, promotes
hepcidin transcription through the BMP/Smad and, probably,
the extracelular signal-related kinase (ERK)/mitogen-activated
protein kinase (MAPK) signaling pathways. In addition, increased
tissue iron activates the Smad pathway by increasing BMP6 pro-
duction. By binding BMP receptors in complex with the hemoju-
velin protein, BMP6 activates the Smad pathway, leading to
increased hepcidin production (Babit et al., 2006). The expres-
sion of iron transporters in the duodenum is also regulated by
the transcription factor HIF2a, which binds to hypoxia-respon-
sive elements in the promoters of feroportin and DMT1 (Mastro-
giannaki et al., 2009).
Dysregulation of hepcidin production, because of a plethora
of genetic defects of iron homeostasis, causes iron overload
and results in a systemic disease known as ‘hereditaryl Reports14, 411–421, January 26, 2016ª2016 The Authors 411
Figure 1. Increased Iron Accumulation in NCOA4-Nul Mouse Liver, Spleen, and Duodenum
(A) Representative Perls’ Prussian blue staining of WT (+/+) and NCOA4-nul (/) spleen sections from 2-month-old female and male mice. Magniﬁcation,320.
(B) Representative Perls’ Prussian blue staining of WT (+/+) and NCOA4-nul (/) liver sections from 2-month-old female and male mice. Magniﬁcation,320.
(legend continued on next page)
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hemochromatosis,’ which is characterized by tissue iron accu-
mulation, iron-mediated injury, and organ dysfunction (Fleming
and Ponka, 2012). Mouse models of hereditary hemochromato-
sis corectly recapitulate various human diseases (Hentze et al.,
2010).
To avoid iron overload, cels shelter iron in feritin. Conse-
quently, a high concentration of iron promotes the translation
of feritin subunits by inactivating the iron regulatory protein
(IRP)/iron-responsive element (IRE) machinery (Zhang et al.,
2014; Zhao et al., 2013). On the contrary, under conditions of
iron deﬁciency or increased iron requirement, mobilization of
iron from feritin deposits is supported via autophagy (‘feriti-
nophagy’) (Mancias et al., 2014).
Protein NCOA4, which interacts with and co-activates several
nuclear hormone receptors and controls DNA replication origin
activation, thereby preserving genome stability (Beleli et al.,
2014; Heinlein et al., 1999; Lanzino et al., 2005; Yeh and Chang,
1996), has been identiﬁed recently as a crucial player in feriti-
nophagy (Dowdle et al., 2014; Mancias et al., 2014). Therefore,
NCOA4 functions as a cargo receptor that, by interacting with
feritin, promotes its transport to autophagosomes via interaction
with ATG8-like proteins such as GABARAP and GABARAPL1,
sustaining iron release under both basal and iron starvation con-
ditions. Inactivation of NCOA4 in cels causes an increase in
feritin deposits (Dowdle et al., 2014; Mancias et al., 2014).
The aim of this study was to explore the involvement of NCOA4
in feritinophagy in vivo using an NCOA4/ mouse model. To
determine the role of NCOA4 in maintaining in vivo iron homeo-
stasis, we exposed NCOA4/ mice to a high- or low-iron diet.
We also evaluated the ability of mouse embryonic ﬁbroblasts
(MEFs) from NCOA4-nul mice to target feritin to autophagoly-
sosomal digestion under basal and iron-depleted conditions.
RESULTS
NCOA4-Nul Animals Display Ferritin Accumulation
To determine whether feritin deposits were enhanced in
NCOA4-nul animals as a consequence of impaired feritinoph-
agy, we analyzed protein extracts from the liver, spleen, duo-
denum, bone marow, and kidney of NCOA4/ and wild-type
(WT) animals by western bloting. As shown inFigure S1, feritin
content (FTH1) was signiﬁcantly higher in NCOA4-nul mice than
in WT mice in al analyzed tissues. Perls’ Prussian blue staining of
the liver, spleen, and duodenum conﬁrmed this ﬁnding (Figures
1A–1C). Consistently, iron concentrations were signiﬁcantly
higher in the spleens and livers of NCOA4-nul than in WT animals
(Figures 1D and 1E).
NCOA4-Nul Animals Display Increased Serum Iron,
Transferrin Saturation, and Hepcidin Upregulation
The percentages of transferin saturation and serum feritin
levels were increased slightly but signiﬁcantly in NCOA4-nul(C) Representative Perls’ Prussian blue staining of WT (+/+) and NCOA4-nul (
cation,320.
(D) Splenic non-heme iron content (SIC) of WT (+/+) and NCOA4-nul (/) female
(E) Liver non-heme iron content (LIC) of WT (+/+) and NCOA4-nul (/) female 
**p < 0.01, ***p < 0.001. See alsoFigures S1,S2, andS3.
Ceversus WT animals (Figures S2A and S2B). This indicates that tis-
sue iron in the knockout animals is in equilibrium with circulating
iron. Generaly, increased transferin saturation activates a
signaling pathway in hepatocytes that leads to increased hepci-
din gene (HAMP) transcription to reduce iron absorption. At real-
time PCR, HAMP mRNA expression was 2-fold higher in
NCOA4-nul livers versus WT tissues (Figure S2C). Western blot-
ting with anti-phospho Smad1/5/8 antibody did not show
increased phosphorylation of Smad proteins in the livers of
knockout animals (data not shown) but, rather, increased phos-
phorylation of proteins ERK1/2 (Figure S2D). Consistent with
increased HAMP expression, FNP protein expression was lower
in the duodeni of NCOA4-nul mice than in those of WT animals
(Figure S3A). NCOA4 deﬁciency did not signiﬁcantly afect the
expression of protein HIF2aor of FPN mRNA in duodenum enter-
ocytes (Figures S3B and S3C). Furthermore, IRP2 protein levels
were not increased in NCOA4-nul mouse livers. This ﬁnding
strongly suggests that, notwithstanding the increase in feritin
content in various tissues, the IRP/IRE and HIF2 systems, which
are mainly inﬂuenced by alteration of labile intracelular iron,
were not afected (Figure S3D). Accordingly, levels of TfR1
mRNA (containing multiple IRE elements in the 30UTR) and pro-
tein were similar in the livers of NCOA4-nul and WT mice (Fig-
ures S3D and S3E), as was FTH1 mRNA expression (Figure S3E).
In summary, NCOA4-nul mice, despite their ability to activate
the hepcidin/feroportin pathway, accumulated iron in tissues.
Notably, no gender diferences were observed.
NCOA4-Nul Mice Display Hypochromic Microcytic
Anemia that Is Exacerbated by a Low Dietary Iron Intake
To determine whether the failure of NCOA4-nul mice to degrade
feritin and mobilize stored iron afects erythropoiesis, we evalu-
ated red blood parameters in NCOA4-nul and WT mice at base-
line and after prolonged exposure to a low-iron diet; namely, for 5
and 7 months. As shown inTable 1, at baseline, compared with
WT animals, NCOA4-nul mice had signiﬁcantly lower values of
hematocrit, hemoglobin, mean corpuscular volume, and mean
corpuscular hemoglobin, a condition compatible with microcytic
anemia.
To examine defective erythropoiesis in greater detail, we
analyzed feritin deposits by western bloting in knockout and
WT animals fed an iron-poor diet (2–3 mg/kg) for 5 months, which
is sufﬁcient time to alow iron mobilization from feritin. As shown
inFigures 2A andS4A, although, after 5 months of iron depletion,
feritin deposits were completely exhausted in WT livers and
spleens, a large amount of feritin was stil present in NCOA4-
nul mice. Indeed, liver and spleen iron content was signiﬁcantly
higher in knockout than in WT animals (Figure 2B). On the con-
trary, serum iron and transferin saturation, which, under a
normal diet, were higher in NCOA4-nul than in WT animals (Fig-
ure S2A; data not shown), were signiﬁcantly lower under a low-
iron diet in NCOA4-nul than in WT animals (Figure 2C)./) duodenum sections from 2-month-old female and male mice. Magniﬁ-
 and male mice. Data are shown as mean±SD from 4–5 independent samples.
and male mice. Data are shown as mean±SD from 4–5 independent samples.
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Table 1. Hematological Parameters and Red Cel Indices in NCOA4+/+and NCOA4/ MICE under Standard and Iron-Deﬁcient Diets
Baseline
Iron-Deﬁcient Diet
5 Months 7 Months
NCOA4+/+
Mice (n = 6)
NCOA4 /
Mice (n = 6)
NCOA4+/+
Mice (n = 6)
NCOA4 /
Mice (n = 6)
NCOA4+/+
Mice (n = 3)
NCOA4 /
Mice (n = 4)
Hct (%) 45.8±1.1 42.2±1.3* 36.7±1.3 28.6±2.8* 36.0±0.6 28.8±3.3*
Hb (g/dl) 15.1±0.2 12.7±0.6* 11.8±0.3 8.8±1.7* 11.0±0.5 8.0±1.8*
MCV (ﬂ) 51.7±0.5 46.3±3.05* 47.5±1.5 38.5±4.1* 43.7±2.7 36.5±2.4*
MCH (pg) 16.3±0.8 15.6±0.2* 15.4±1.2 10.3±0.9* 14.1±1.3 10.4±1.5*
MCHC (g/dl) 27.6±0.4 28.2±0.5 27.5±0.3 26.1±0.9* 26.7±0.6 26.7±0.6
CH (pg) 14.9±0.3 13.0±0.5 13.1±0.6 9.92±0.9* 10.12±0.4 9.57±0.86
RDW (%) 12.6±0.5 15.1±2.5 13.1±0.7 23.4±4.0* 30.12±6.1 28±7.3*
Retics (103cel/ml) 498±84 488±170 419±98 60±2.8* 41±15 52±0.8
MCVr (ﬂ) 55.2±0.4 51±1.84* 53.6±1.9 48.5±5.4* 41.6±5 40.2±2.8
CHr (pg) 14.7+0.8 13.8±1.1 13.45±1.5 11.0±0.78* 13.5±1.1 9.05±1.3*
Hct, hematocrit; Hb, hemoglobin; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin con-
centration; CH, hemoglobin concentration; RDW, red cel distribution width; Retics, reticulocytes; MCVr, reticulocyte mean corpuscular volume; CHr,
reticulocyte hemoglobin concentration. *p < 0.05 compared with WT mice;p < 0.05 compared with baseline.Consistent with this ﬁnding, hepcidin mRNA levels were sup-
pressed completely in NCOA4/ livers, whereas feroportin
protein expression was increased signiﬁcantly in spleen macro-
phages despite the accumulation of feritin in the spleen (Figures
S4B and S4C).
These data strongly indicated that NCOA4-nul animals were
unable to mobilize iron from ferritin deposits when subjected
to an iron depletion regimen. Therefore, we explored the
efects of a low-iron diet on red cels and erythropoiesis.
After 5 months of a low-iron diet, NCOA4-nul mice developed
severe hypochromic microcytic hyporegenerative anemia
and anisopoikilocytosis (Figure 2D). This was associated
with signiﬁcantly lower values of hemocrit, hemoglobin, mean
corpuscular volume, mean corpuscular hemoglobin, mean
corpuscular hemoglobin concentration, hemoglobin concen-
tration, reticulocytes, and a signiﬁcantly lower reticulocyte
mean corpuscular volume in NCOA4-nul than in WT mice
(Table 1). After 7 months of a low-iron diet, the hypochromic
microcytic anemia became more severe in NCOA4 / mice,
and the reticulocyte hemoglobin concentration was signiﬁ-
cantly lower than in WT mice. These results indicate a severe
reduction in the availability of iron required for cel hemoglobi-
nization (Figure 2D;Table 1). Notably, WT mice developed
only mild hypochromic anemia after 5 months of a low-iron
diet and severe microcytic and hypo-regenerative anemia after
7 months of a low-iron diet (Figure 2D;Table 1). Consistently,
erythropoietin expression was signiﬁcantly higher in NCOA4-
nul than in WT animals after both 5 and 7 months of a low-
iron diet (Figure 2E).
To characterize the diferent forms of anemia, we explored
NCOA4-nul mice erythropoiesis using a recently developed
ﬂow cytometry strategy. This strategy combines CD44 and
TER119 positivity with cel size to quantify terminal erythroid dif-
ferentiation by sorting bone marow erythroid precursors at each
distinct developmental stage (population I, pro-erythroblasts;
population I, basophilic erythroblasts; population II, polychro-414 Cel Reports14, 411–421, January 26, 2016ª2016 The Authorsmatic erythroblasts; population IV, orthochromatic erythro-
blasts) (Liu et al., 2013). As shown inFigure 2F, after 7 months
of a low-iron diet, the decrease in FschighCD44+Ter119+cels
was more pronounced in NCOA4-nul mice than in WT animals.
The process of terminal erythroid diferentiation did not difer
substantialy between untreated NCOA4-nul and WT mouse
bone marow (Figure S4D). However, at the same time
point, orthochromatic erythroblasts were signiﬁcantly fewer in
NCOA4-nul mice than in WT animals (Figure 2G). The decrease
in orthochromatic erythroblasts was associated with signiﬁ-
cantly higher amounts of apoptotic orthochromatic erythroblasts
in NCOA4-nul mice than in WT mice already after 5 months of
diet (Figure S4E). The number of apoptotic orthochromatic eryth-
roblasts increased in WT mice only after 7 months of a low-iron
diet (data not shown). Overal, these data indicate that genetic
inactivation of NCOA4 impairs the mobilization of iron from liver
and spleen deposits, thereby promoting anemia, particularly un-
der conditions of iron deﬁciency.
NCOA4-Nul Animals Are Hypersensitive to an
Iron-Rich Diet
Increased iron deposits in NCOA4-nul mice tissues (Figure 1;
Figure S1) suggested that these animals might poorly tolerate
an increased iron intake. To explore this possibility, knockout
and WT animals were fed chow containing 2 g/kg iron. After
15 days of a hyperferic diet, both FTH1 protein levels and iron
content were higher in NCOA4/ liver extracts than in the WT
counterparts (Figures 3A and 3B). Furthermore, Perls’ Prussian
blue staining was more intense and difuse in NCOA4/ than
in WT livers (Figure 3C). Saturation of feritin deposits presum-
ably leads to an increase of free iron concentration and Fenton
reaction-mediated oxidative stress, which causes hepatocyte
damage and, eventualy, cel death. Hepatocytes react to oxida-
tive stress by activating the transcription of scavenger proteins
such as superoxide dismutase (SOD) and glutathione peroxi-
dase (GPx) (Vanoaica et al., 2010). Consistent with an increased
(legend on next page)
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reactive oxygen species (ROS) concentration in NCOA4/ he-
patocytes, SOD and GPx gene expression was signiﬁcantly
higher in NCOA4/ than in WT hepatocytes (Figure 3D). To
verify hepatocyte cel damage, we measured the concentrations
of alanine and aspartate liver transferases (ALT and AST, res-
pectively), which are considered a bona ﬁde measure of liver
damage, in NCOA4-nul and WT animals after 1 month of a hy-
perferic diet. As shown inFigure 3E, both enzymes were signif-
icantly higher in NCOA4-nul animals than in WT mice, indicating
precocious hepatic damage in knockout animals. Indeed, after
2 months of a hyperferic diet, faty degeneration, which is a
sign of hepato-steatosis, was more pronounced in livers of
NCOA4-nul than in those of WT mice, indicating more severe
tissue damage in the former animals (Figure 3F). Finaly,
NCOA4-nul animals started to die 75 days after diet onset,
whereas WT animals started to die only after 100 days. Mean
survival was 89 days in NCOA4-nul animals and 104 days in
WT animals, which coresponds to a 15% reduction in the
mean survival of NCOA4-nul mice (Figure 3G).
NCOA4-Nul Mouse Embryonic Fibroblasts Display
Impaired Ferritinophagy
To functionaly verify the above results, we immortalized MEFs
from NCOA4-nul and WT mice in culture and evaluated their
ability to target feritin to autophagolysosomal digestion under
both basal and iron-depleted conditions. Initialy, we studied
the intracelular localization of feritin by confocal immunoﬂuo-
rescence analysis of MEFs treated with chloroquine, which, by
inhibiting autophagosome-lysosome fusion and lysosomal pro-
tein degradation, reveals proteins contained in autophagosomes
(Klionsky et al., 2012). As shown inFigure 4A, feritin co-localized
with LC3B-positive autophagosomes in WT MEFs, whereas
feritin was dispersed in the cytoplasm of NCOA4-nul cels.
In addition, western bloting showed that feritin accumulation
at steady-state was higher in NCOA4-nul MEFs than in WT
MEFs, which suggests reduced targeting of feritin to autophagy
in the former animals (Figure 4B). Consistently, when treated with
feric ammonium citrate (to induce iron accumulation in feritin
deposits) folowed by the iron chelator deferoxamine (to promote
iron release by feritin digestion), WT MEFs rapidly degradedFigure 2. Defective Iron Release from Ferritin Storage and Impaired Er
(A) Western blot analysis of FTH1 protein levels from WT (+/+) and NCOA4-nul (
Tubulin was used as loading control.
(B) Left: LIC of WT (+/+) and NCOA4-nul (/) mice fed an iron-depleted diet (5 m
diet (5 months). Data are shown as mean±SD of 4 independent samples (*p < 0
(C) Left: serum iron concentration of WT (+/+) and NCOA4-nul (/) mice fed an 
(+/+) and NCOA4-nul (/) mice fed an iron-depleted diet (5 months). Data are 
(D) Representative May-Gr€unwald-Giemsa staining of peripheral blood smears fr
7 months to a low-iron (2–3 mg Fe/kg of food) diet. Original magniﬁcation,340.
(E) Relative erythropoietin mRNA expression in kidneys from WT (+/+) and NCOA
two females and six males) and after 5 months (+/+, three females; /, three fe
(*p < 0.05, **p < 0.01).
(F) Percentage of CD44+/CD119+/fsc-high bone marow cels in WT (+/+) and NC
/, three females and three males) and after 5 months (+/+, three females and t
/, four males) of iron-deﬁcient diet (*p < 0.05).
(G) Flow cytometry analysis combining CD44, CD119, and cel size as markers to s
erythroblasts; population I, basophilic erythroblasts; population II, polychromati
See alsoFigure S4.
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feritin digestion in NCOA4-nul cels was much slower, with
more than 50% of deposits being present 9 hr after treatment
(Figure 4C).
NCOA4 promotes feritinophagy by directly interacting with
the ATG8-like proteins GABARAP and GABARAPL1, localized
on the membrane of autophagic vesicles, but not with the
ATG8-like protein LC3B (Mancias et al., 2014). To study the mo-
lecular determinants of NCOA4-mediated interaction with the
autophagosome receptors, we performed pul-down experi-
ments with HEK293 cel extracts exogenously expressing the
myc-tagged ful-length NCOA4, the hemagglutinin (HA)-tagged
N-terminal (N) NCOA4 (1–238 amino acids [aa]), and the C-termi-
nal (C) NCOA4 (239–618 aa) using glutathione S-transferase
(GST)-fused recombinant proteins of the ATG8-like polypeptides
LC3B, GABARAP, and GABARAPL1. As reported by Mancias
et al. (2014), ful-length NCOA4 was puled down by GABARAP
and GABARAPL1 but not by LC3B (Figure S5A). Interestingly,
only the NCOA4 (C), but not the NCOA4 (N) fragment, was able
to bind to both GST-GABARAP and GST-GABARAPL1 (Fig-
ure S5B). To identify the NCOA4 protein domain responsible
for interaction with feritin, we then performed pul-down exper-
iments using NUS-NCOA4, NUS-NCOA4 (C), and NUS-NCOA4
(N) recombinant proteins together with the isolated NUS moiety.
As shown inFigure S5C, both NUS-NCOA4 and NUS-NCOA4 (C)
were able to pul down feritin whereas NUS and NUS-NCOA4
(N) were not, suggesting that the C-terminal fragment of
NCOA4 protein mediates interaction with both feritin and the au-
tophagosomal machinery.
Confocal microscopy of EGFP-GABARAP- and EGFP-GA-
BARAPL1-transfected HeLa cels conﬁrmed that, like the ful-
length NCOA4 protein, the NCOA4 COOH-terminal fragment
was able to localize to autophagosomes whereas the NCOA4
NH2-terminal fragment was not (Figures S5D and S5E). Finaly,
like the WT protein, the NCOA4 COOH-terminal fragment was
able to complement NCOA4-nul MEF-impaired feritinophagy
whereas the NCOA4 N-terminal fragment was not (Figure 4D).
In summary, these data indicate that the NCOA4 COOH-terminal
fragment is necessary and sufﬁcient for interaction with both
feritin and autophagosomes and for promoting feritinophagy.ythropoiesis in NCOA4-Nul Mice
/) female mice fed an iron-depleted diet for 5 months (2–3 mg Fe/kg of food).
onths). Right: SIC of WT (+/+) and NCOA4-nul (/) mice fed an iron-depleted
.05).
iron-depleted diet (5 months). Right: percentage of transferin saturation of WT
shown as mean±SD of 4 independent samples (*p < 0.05).
om WT (+/+) and NCOA4-nul ( /) mice subjected or not subjected for 5 or
4-nul (/) mice under basal conditions (+/+, two females and ﬁve males;/,
males) or 7 months (+/+, three males; /, four males) of an iron-deﬁcient diet
OA4-nul (/) mice under basal conditions (+/+, three females and three males;
hree males;/, three females and three males) or 7 months (+/+, three males;
ort erythroid precursors at each distinct developmental stage (population I, pro-
c erythroblasts; population IV, orthochromatic erythroblasts).
Figure 3. Iron Overload Leads to Liver Damage and Reduces Survival of NCOA4-Nul Mice
(A) Western blot analysis of FTH1 protein levels from WT (+/+) and NCOA4-nul (/) mice fed an iron-rich diet for 15 days. Tubulin was used as a loading control.
The samples were run on the same SDS-PAGE gel and transfered and hybridized on the same ﬁlter. They were mounted separately because we did not include
unrelated samples that were loaded in the central wels of the gel.
(B) LIC of WT (+/+) and NCOA4-nul (/) mice subjected to a high-iron diet for 15 days. Data are shown as mean±SD from 4–5 independent samples. (*p < 0.05).
(C) Representative Perls’ Prussian blue staining of WT (+/+) and NCOA4-nul (/) liver sections from mice subjected to an iron-rich diet for 15 days. Magniﬁ-
cation,320.
(D) Real-time PCR of SOD and GPx mRNA expression in livers from NCOA4+/+and NCOA4/ mice subjected to a hyperferic diet for 1 month (*p < 0.05).
(legend continued on next page)
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DISCUSSION
NCOA4 promotes autophagic feritin degradation to mobilize
iron from deposits under both normal and iron-depleted condi-
tions in vitro (Mancias et al., 2014; Dowdle et al., 2014). Here
we describe the role of NCOA4 in controling iron homeostasis
in vivo. Loss of NCOA4 function induced feritin accumulation
in al analyzed tissues. Therefore, liver and spleen iron content
were signiﬁcantly higher in knockout than in WT animals. Trans-
ferin saturation and serum feritin were signiﬁcantly higher
in knockout than in WT animals and were probably sustained
by iron overload in tissues. This phenotype resembles that
described byIolascon et al. (2006)in a patient carying
genetic inactivation of the DMT1 gene and displaying hepatic
iron overload, microcytic hypochromic anemia, and increased
levels of transferin saturation. Increased transferin saturation
in NCOA4-nul mice presumably leads to increased hepcidin
mRNA levels, possibly consequent to activation of the TfR2/
HFE receptor complex, as suggested by the increased activation
of the ERK pathway. In turn, increased hepcidin reduces FNP
levels in duodenal enterocytes, limiting iron absorption. Such a
compensating mechanism could be responsible for the mild na-
ture of the iron overload phenotype displayed by NCOA4-nul
animals.
Despite their ability to produce hepcidin to compensate for
tissue iron overload, NCOA4-nul mice subjected to a high iron
content diet displayed early signs of steatohepatitis, as wit-
nessed by increased serum transaminase levels and increased
liver fat deposition. The low survival time of knockout animals
on a hyperferric diet is probably due to the enhanced levels
of basal tissue iron, which may accelerate saturation of
the detoxiﬁcation pathways that protect cels against the
deleterious efects of iron-dependent oxidative reactions.
Al previous mouse models of hereditary hemochromatosis
are based on the absence of either hepcidin production or
resistance to hepcidin action, whereas NCOA4-nul animals
are fuly competent for hepcidin production and activity on
duodenal ferroportin, as shown by decreased levels of ferro-
portin in NCOA4-nul duodenal enterocytes (Figure S3A).
Therefore, to our knowledge, NCOA4-nul mice represent the
ﬁrst example of a hepcidin-independent model of tissue he-
mochromatosis. Although no NCOA4 mutations have yet
been identiﬁed in patients, this gene might represent a candi-
date modiﬁer of iron overload diseases, which are often asso-
ciated with a variable phenotype and incomplete penetrance
(Fleming and Ponka, 2012).
Our data also indicate that impaired NCOA4 function predis-
poses to iron deﬁciency anemia, especialy in animals fed a
low-iron diet. Various observations have implicated NCOA4 in
erythropoiesis. For instance, NCOA4 is highly expressed in
erythroid precursors (htps:/genome-euro.ucsc.edu/). It is also
particularly expressed during erythropoiesis in zebraﬁsh mutants
harboring defects of speciﬁc stages of hematopoiesis (Weber(E) AST and ALT levels in WT (+/+) and NCOA4-nul (/) mice subjected to a h
(F) Representative H&E staining of liver sections from WT (+/+) and NCOA4-nul 
(G) Kaplan-Meier survival curve of ten WT (+/+) (two females and eight males) and t
to a hyperferic diet (2 g Fe/kg of food).
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that NCOA4 plays an essential role in erythropoiesis in zebraﬁsh
embryos and cultured erythrocytes. Our mouse model suggests
that the absence of NCOA4 also favors anemia in adult animals
and under unstressed erythropoietic conditions. In fact, the use
of iron deposits is impaired in NCOA4-nul animals, inducing
a peculiar mild hypochromic microcytic anemia associated
with increased tissue iron content and transferin saturation.
These data suggest that, during erythroblast development,
when liberated from transferin, iron is, at least in part, stored
intermediately in feritin. In the absence of NCOA4, use of the
feritin-bound iron pool would be limited. Under hypoferic con-
ditions, NCOA4-nul mice develop severe anemia because of a
remarkable reduction in circulating iron and inefective erythro-
poiesis associated with reduction of the erythroid mass and
increased apoptosis of orthochromatic erythroblasts. In this
view, NCOA4 might also represent a modiﬁer of genetic predis-
position to iron deﬁciency.
Besides controling feritinophagy, NCOA4 has also been
described as a coactivator of nuclear receptors and, in partic-
ular, of androgen receptor-, estrogen receptor-, and peroxisome
proliferator-activating receptorg(Heinlein et al., 1999; Yeh and
Chang, 1996). We showed recently that NCOA4 controls DNA
replication origin activation by inhibiting the processive helicase
of the replication fork; i.e., the MCM2-7 complex, via its NH2-ter-
minal portion (Beleli et al., 2014). Interestingly, in their proteomic
screening for NCOA4-interacting polypeptides,Mancias et al.
(2014)andDowdle et al. (2014)identiﬁed several MCM2-7 com-
plex components. Moreover, the protein HERC2, which is an
important player in the DNA damage response and in DNA repli-
cation origin activation, has been found to bind NCOA4 in an
iron-dependent manner, promoting its ubiquitination and pro-
teosomal degradation (Bekker-Jensen et al., 2010; Izawa et al.,
2011; Mancias et al., 2015).
In structure-function experiments, we observed that the
COOH-terminal portion of NCOA4 was necessary and sufﬁcient
to interact with both feritin and ATG8-like proteins and that it
was also able to complement feritinophagy in NCOA4-nul
MEFs. This is in line withMancias et al. (2015), who recently
demonstrated that NCOA4 binding to FTH requires residues
I489 and W497, both of which are contained in the COOH-termi-
nal portion of the protein. Our data also indicate that the NCOA4
oligomerization motif contained within the protein’s NH2-termi-
nal portion is dispensable for feritinophagy. Therefore, the two
NCOA4 functions are separated structuraly: the NH2-terminal
portion interacts with DNA replication machinery, and the
COOH-terminal portion interacts with the players crucial for fer-
ritinophagy. Whether and how these distinct functions might
crosstalk is unknown. It is conceivable that the regulation of
intracelular iron concentrations needs to be coordinated with
features of DNA metabolism; namely replication and transcrip-
tion. In this context, it should be noted that many enzymes
involved in DNA replication contain iron and that, during DNAyperferic diet for 1 month (**p < 0.01).
(/) mice subjected to a hyperferic diet for 2 months.
en NCOA4-nul (/) (two females and eight males) 4-week-old mice subjected
Figure 4. NCOA4-Nul MEFs Show Defective Ferritinophagy
(A) Immunoﬂuorescence analysis of LC3B (green) and Feritin (red) co-localization in NCOA4 WT (+/+) and NCOA4-nul (/) cels treated with chloroquine.
Arows indicate co-localization in merged images.
(B) Western blot analysis of IRP2, NCOA4, and FTH1 expression in three diferent WT (+/+) and NCOA4-nul (/) MEF clones. The asterisk indicates an un-
speciﬁc band. Tubulin was used as a loading control.
(legend continued on next page)
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and RNA synthesis, the double helix is more sensitive to oxida-
tive damage, being less sheltered by chromatin proteins. In addi-
tion, erythropoiesis has been linked directly to iron availability.
Indeed, iron deﬁciency blocks erythrocyte production (Kim and
Nemeth, 2015). Our data suggest that NCOA4 might be involved
in coupling the proliferation of erythroblasts with iron availability
so that, under conditions of iron depletion, the lack of NCOA4 re-
sults in severe impairment of erythropoiesis.
EXPERIMENTAL PROCEDURES
NCOA4 / Mice
Generation of NCOA4 / mice is described inBeleli et al. (2014).
Details about animal care and management are provided in theSupple-
mental Experimental Procedures.
Cel Culture
WT and NCOA4-nul MEFs were produced and cultured as described byBel-
leli et al. (2014). HeLa cels were cultured in DMEM supplemented with 10%
fetal bovine serum (FBS), 50mg/ml penicilin-streptomycin, and 2 mM L-gluta-
mine. To induce iron-replete conditions, MEFs were treated with 10mg/ml of
ferum ammonium citrate (FAC), whereas, for growth under iron-deﬁcient con-
ditions, cels incubated for 24 hr in FAC were released in normal medium con-
taining 50mM deferoxamine (DFO). Chloroquine (Sigma-Aldrich) was used at a
ﬁnal concentration of 25mM.
Histology
Formalin-ﬁxed, parafﬁn-embedded (FFPE) sections (5mm thick) were stained
with H&E by conventional methods or deparafﬁnized and rehydrated by pas-
sages through xylene and alcohol series for Perl’s Prussian blue or immunohis-
tochemical (IHC) staining. The IHC staining protocol is described in theSup-
plemental Experimental Procedures.
Hematological Parameters and Red Cel Indices
Blood was colected by retro-orbital venipuncture in anesthetized mice using
heparinized microcapilary tubes. Hematological parameters were evaluated
on a Bayer Technicon Analyzer ADVIA. Hematocrit and hemoglobin were
determined manualy as described previously (Franco et al., 2014). Blood
smears were stained with May-Gr€unwald-Giemsa (Sigma-Aldrich) for morpho-
logical analysis. Images were captured using a Nikon EclipseE600
microscope.
Flow Cytometric Analysis of Mouse Bone Marrow and Spleen
Precursors
Flow cytometric analysis of erythroid precursors from mouse bone marow
was caried out as described byLiu et al. (2013). The cel staining and analysis
procedures are reported in theSupplemental Experimental Procedures.
RNA Extraction and RT-PCR
RNA was isolated from snap-frozen mouse tissues by using TRIzol reagent (In-
vitrogen) and puriﬁed with the RNeasy puriﬁcation kit (QIAGEN). RNA (1mg)
was reverse-transcribed with a Quantitec reverse transcription kit (QIAGEN).
qRT-PCR reactions were done in triplicate, and fold changes were calculated
with the folowing formula: 2 (sample 1DCt sample 2DCt), whereDCt is the difer-(C) Left: western blot analysis of FTH1 in WT (+/+) and NCOA4-nul (/) cels un
released at the reported time points in medium containing the iron chelator DF
speciﬁc band. Right: curves showing FTH1 degradation kinetics in WT (+/+) and
experiments performed in triplicate.
(D) Top: western blot analysis of FTH1 degradation in primary NCOA4-nul ME
NCOA4), or the C-terminal (pB NCOA4 (C) or N-terminal (pB NCOA4 (N) NCOA
infected with the described constructs. The percentage of protein levels compar
See alsoFigure S5.
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and the mRNA of theb-actin used as an internal reference. The primer se-
quences used for qPCR are available upon request.
Protein Studies
Details regarding the preparation of protein cel lysates, immunoprecipitation,
and western bloting can be found in theSupplemental Experimental Proce-
dures. Densitometric analysis of signal was performed using ImageQuant.
Antibodies
Anti-IRP2 antibody was from Santa Cruz Biotechnology. Anti-FTH1, anti-
MAPK, and anti-pMAPK were from Cel Signaling Technology, and anti-trans-
ferin receptor was from Invitrogen. Anti-FPN for IHC was from Alpha Diagnos-
tics International, and anti-HIF2awas from Novus Biologicals. Anti-tubulin was
from Sigma-Aldrich. Anti-NCOA4 is an afﬁnity-puriﬁed rabbit polyclonal anti-
body raised against the C-terminal protein fragment of human NCOA4 (amino
acids 239–614) (Beleli et al., 2014). Secondary antibodies coupled to horse-
radish peroxidase were from Santa Cruz Biotechnology.
Tissue and Serum Iron Determination
For iron concentration measurements, mouse spleen and liver tissues were
dried overnight at 110C, dissociated mechanicaly, weighed, and digested
in 1 ml of 3M HCl and 0.6 M trichloroacetic acid for 20 hr at 65C. The total
non-heme iron content was then measured using the bathophenanthroline
method as described byTorrance and Bothwel (1968). Serum iron and trans-
ferin saturation (the ratio of serum iron and total iron binding capacity) were
calculated using the serum iron/unsaturated iron binding capacity (UIBC)
and the total iron binding capacity (TIBC) kits (Randox Laboratories) according
to the manufacturer’s instructions.
Transduction of Retrovirus-Mediated MEFs
pBABE Puro NCOA4, NCOA4 (N), and NCOA4 (C) or the empty vector were
transfected into Phoenix-eco cels, and, 48 hr later, viral supernatants were
harvested and used to infect primary NCOA4-nul MEFs. Forty-eight hours af-
ter infection, cels were selected with Puromycin (2.5 mg/ml) and used to
analyze feritin accumulation and degradation upon FAC treatment and
release in DFO, as reported underCel Culture.
Immunoﬂuorescence Staining
For indirect immunoﬂuorescence, cels were ﬁxed in 4% paraformaldehyde,
permeabilized with 0.2% Triton X-100 (5 min on ice), and then incubated
with the appropriate antibodies. The immunoﬂuorescence staining procedure
is reported in theSupplemental Experimental Procedures.
Recombinant Proteins
NUS-NCOA4, NUS-NCOA4(N), and NUS-NCOA4(C) recombinant proteins
were generated as described byBeleli et al. (2014)and produced inEscher-
ichia coliusing standard protocols. GST-GABARAP, GST-GABARAPL1, and
GST-LC3B recombinant proteins are described byColecchia et al. (2012).
Statistics
Two-tailed unpaired Student’s t test was used for statistical analysis. Al p
values were two-sided, and diferences were considered signiﬁcant when p
was less than 0.05. Al statistical analyses were caried out using GraphPad In-
stat software (version 3.06.3).der iron-depleted conditions. Cels were incubated for 24 hr with FAC and then
O. NCOA4 and tubulin western blots are shown. The asterisk indicates an un-
 NCOA4-nul (/) MEFs. Values are represented as the mean±SD of three
Fs infected with retrovirus expressing empty vector (pBABE), NCOA4 WT (pB
4 deletion mutants. Botom: FTH1 degradation kinetics in NCOA4-nul MEFs
ed with the control was measured by densitometric analysis using ImageQuant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and ﬁve ﬁgures and can be found with this article online athtp:/dx.doi.org/
10.1016/j.celrep.2015.12.065.
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SUPPLEMENTAL INFORMATION  
 
Supplemental Experimental Procedures 
 
NCOA4 -/- Mice. Animals were maintained under a standard diet of 480 mg iron/kg (Harlan Teklad, Madison, 
WI, USA) or subjected to iron-depleted diet (2-3 mg iron/kg, Harlan Teklad) or iron overload (2 g iron/kg, Harlan 
Teklad) starting from 4 weeks of age. Mice were maintained under specific pathogen-free conditions in the animal 
facility of the Dipartimento di Medicina Molecolare Biotecnologie Mediche (University of Naples Federico II).All 
studies were conducted in accordance with the Italian regulations for experiments involving animals. Genetic 
screening of mice and MEFs was conducted by genomic PCR as described in Bellelli et al. (2014). 
 
Histology. Endogenous peroxidase activity was blocked by treatment with 3% hydrogen peroxide (30 min at room 
temperature). Antigens were retrieved by incubating tissue sections for 15 min in boiling citrate buffer (1 mM, pH 
6.0). Slides were blocked in 1% BSA for 1h at room temperture followed by o.n. incubation with primary 
antibodies and for 30 min at room temperature with biotinylated goat anti-rabbit antibody (Vector Laboratories, 
Burlingame, CA, USA); the stain was visualized with 3,3'-Diaminobenzidine (DAB) (SIGMA-Aldrich).  
 
Flow Cytometric Analysis of Mouse Bone Marrow and Spleen Precursors. CD16/CD32 (BD Biosciences, 
Mountain View, CA, USA), CD44-FITC (eBioscience, San Diego, CA USA), TER-119 APC (eBioscience), 
CD45 APC-eFluor 780 (eBioscience), GR1 APC-Cy7 (BD Biosciences), CD11b APC-Cy7 (BD Biosciences) 
were used. The 7AAD Viability staining solution (eBioscience) was used to remove dead cells from the analysis. 
Flow cytometry was carried out with the FACSCantoTM flow cytometer (Becton Dickinson, San Jose, CA, USA) 
equipped with the FACSDiva software (Becton Dickinson). Data were analyzed with the FlowJo software (Tree 
Star, Ashland, OR, USA). Apoptotic orthochromatic erythroblasts were analysed in the CD44-Ter-119 gated cells 
using the Annexin-V PE Apoptosis detection kit (eBioscience) following the manufacturer instructions. Flow 
cytometry was carried out with the FACSCantoTM flow cytometer (Becton Dickinson) as described in Franco et al. 
2014. 
 
Protein Studies. Cells and tissues were lysed in a buffer containing 50 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid pH 7.5), 1% (vol/vol) Triton X-100, 150 mM NaCl, 5 mM EGTA, 50 mM NaF, 20 mM 
sodium pyrophosphate, 1 mM sodium vanadate, 2 mM phenylmethylsulphonyl fluoride and 1 µg/ml aprotinin. 
Lysates were clarified by centrifugation at 10,000 x g for 20 min. Lysates containing comparable amounts of 
proteins, estimated by a modified Bradford assay (Bio-Rad, Munchen, Germany), were immunoprecipitated with 
the required antibody or subjected to direct Western blotting. Immune complexes were detected with the enhanced 
chemiluminescence kit (Amersham Pharmacia Biotech, Little Chalfort, UK). Immunoblotting was carried out with 
specific antibodies. For binding assay (pull-down), HeLa cell lysates were incubated with 5 µg of immobilized 
fusion proteins. Bound proteins were detected by immunoblot analysis.  
 
Immunofluorescence Staining. For indirect immunofluorescence, cells were fixed in 4% paraformaldehyde, 
permeabilized with 0.2% Triton X-100 (5 min on ice), and then incubated with anti-LC3B (Cell Signalling 
Technologies) and anti-Ferritin (Rockland, Limerick, PA, Ireland) or anti-Myc tag (Santa Cruz Biotechnology) for 
1h at room temperature. Coverslips were washed and incubated with Alexa Fluor 488 goat anti-rabbit or anti-
mouse antibodies (Invitrogen) for 30 min at room temperature. After 5 min of DRAQ5 (Cell Signalling 
Technologies) or Hoechst 33258 (Sigma-Aldrich) counterstaining, coverslips were mounted in glycerol/PBS (1:1) 
and observed with a Zeiss LSM 510 META confocal microscope (Carl Zeiss, Jena, Germany).  
 
Supplemental Figure Legends 
Figure S1. Increased Ferritin Protein Levels in NCOA4-Null Mice Tissues. Supplemental to Figure 1 
Left: Western blot analysis of FTH1 protein levels in the indicated tissues from 2 months old wild type (+/+) and 
NCOA4-null (-/-) female and male mice. Tubulin was used as loading control. Right: Bar graph showing the 
relative fold increase in FTH1 level in NCOA4 -/- mice compared to wild type. Densitometric analysis was 
performed using ImageQuant. Data are shown as mean ± SD (*p< 0.05, **p< 0.01). 
 
Figure S2. Increased Transferrin Saturation, Serum Ferritin Levels and Hepcidin Expression in NCOA4-
Null Mice. Supplemental to Figure 1 
(A) Bar graphs showing percentage of transferrin saturation from wt (+/+) and NCOA4-null (-/-) 2 months old 
female and male mice. Data are shown as mean ± SD from 4 independent samples. (*p<0.05). (B) Bar graphs 
showing serum ferritin levels from wt (+/+) and NCOA4-null (-/-) 2 month old female and male mice. Data are 
shown as mean ± SD from 4 independent samples. (*p<0.05, ** p< 0.01). (C) Bar graphs showing liver hepcidin 
(HAMP) mRNA expression levels from wt (+/+) and NCOA4-null (-/-) 2 months old female and male mice. Data 
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are shown as mean of 3 experiments ± SD (** p< 0.01). (D) Western blot analysis of p-MAPK from liver extracts 
of wt (+/+) and NCOA4-null (-/-) 2 months old female and male mice. Total MAPK levels were used as control.  
 
Figure S3. Ferroportin, HIF2α, IRP2 and TfR Levels in NCOA4-Null and Wild-Type Mice. Supplemental 
to figure 1 
(A) Representative immunohistochemical analysis of ferroportin (FPN) in duodenum sections from 6 months old 
NCOA4 +/+ and -/- mice. (B) Western blot analysis of HIF2α protein levels in NCOA4 +/+ and -/- duodenum 
from 2 months old female and male mice. (C) Real-time RT-PCR of FPN mRNA from wild type (+/+) and 
NCOA4 null (-/-) 2 months old female and male mice. Data are the mean ± SD of triplicate experiments. (D) 
Western blot analysis of IRP2 and TfR protein levels in livers from wild type (+/+) and NCOA4 null (-/-) 2 
months old female and male mice. (E) Real-time RT-PCR of the indicated liver mRNAs from wild type (+/+) and 
NCOA4 null (-/-) female 2 months old mice. Data are the mean ± SD of two experiments performed in triplicate. 
 
Figure S4. Defective Iron Mobilization and Analysis of Erythroid Precursors in NCOA4 WT and Null Mice. 
Supplemental to Figure 2 
(A) left: Western blot analysis of FTH1 protein levels in NCOA4 +/+ and -/- liver extracts from mice subjected to 
a normal or hypoferric (2-3 mg iron/kg of food) diet for three months. Right: Bar graph showing the relative fold 
change in FTH1 levels in NCOA4 +/+ and -/- livers from mice subjected or not to a hypoferric diet. Densitometry 
was performed using ImageQuant. Data are shown as mean ± SD. (B) Real-time PCR for Hamp mRNA levels in 
livers from NCOA4 +/+ and -/- mice subjected to a hypoferric diet for three months. Data are shown as mean ± 
SD. (C) Representative immunohistochemical staining for ferroportin (FPN) of NCOA4 +/+ and -/- spleens from 
mice subjected to a hypoferric diet for three months. (D) Percentage of erythroid precursors at each developmental 
stage (population I: pro-erythroblasts; population II: basophilic erythroblasts; population III: polychromatic 
erythroblasts; population IV: orthochromatic erythroblasts) are indicated. Cells were sorted by flow cytometry 
analysis combining CD44, CD119 and cell size as markers. (E) Bar graphs showing percentage of Annexin V-
positive cells in population IV (orthochromatic erythroblast) from bone marrow of 6 months old wt (+/+) and 
NCOA4-null (-/-) mice under basal conditions (+/+: 3 females and 3  males; -/-: 3 females and 3 males) or after 5 
months of iron-deficient diet (+/+: 3 females and 3 males; -/-: 3 females and 3 males) (* p<0.05). 
 
 
Figure S5. NCOA4 (C) Protein Fragments Interact With Ferritin and ATG8-Like Proteins. Supplemental 
to Figure 6 
(A and B) Protein extracts from HEK 293 cells exogenously expressing myc-tagged full-length NCOA4, HA-
tagged NCOA4 (N) and NCOA4 (C) proteins were pulled-down using the LC3B, GABARAP and GABARAPL1 
GST-fused recombinant proteins. Isolated proteins were subjected to Western blotting using the indicated 
antibodies (upper panels). The gel was coloured with Coomassie staining to visualize the input of recombinant 
proteins (lower panels). (C) HeLa cell protein extracts were subjected to pull-down assay with the indicated 
recombinant proteins. Isolated proteins were subjected to Western blotting using the indicated antibody (upper 
panel). The filter was coloured with Ponceau staining to visualize the input of recombinant proteins (lower panel). 
(D and E) Confocal microscopy of HeLa cells transiently transfected with EGFP-GABARAP or EGFP-
GABARAPL1 together with myc-tagged full-length NCOA4, HA-tagged NCOA4 (N) and NCOA4 (C) expressing 
vectors stained with the indicated antibodies. On the right is a merge of the same sections stained with α-
GABARAP or GABARAPL1 (green) and α-myc or HA (red). Arrows indicate co-localization (yellow). 
 
 





